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Abbreviations 
AAC (azide-alkyne cycloaddition), AIBN (azobisisobutyronitrile), AgNP (silver nanoparticle), 
Alk (alkyne), ATRP (atom transfer radical polymerization), AuNP (gold nanoparticle), Az 
(azide), BNP (bionanoparticle), BPDS (bathophenanthroline disulphonated disodium salt), CD 
(cyclodextrin), CMC (critical micelle concentration), CNT (carbon nanotube), CPMV (cowpea 
mosaic virus), CTA (chain transfer agent), CuAAC [Cu(I)-catalyzed azide-alkyne cycloaddition], 
DBU (1,8-diazabicyclo[5.4.0]undec-7-ene), DDS (drug delivery system), DIPEA (N,N-
diisopropylethylamine), DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), DOX 
(doxorubicin), EGF (epidermal growth factor), EGFP (enhanced green fluorescent protein), EPL 
(expressed protein ligation), EPR (enhanced permeability and retention), FA (folic acid), FRET 
(fluorescence resonance energy transfer), FPLC (fast protein liquid chromatography), FR (folate 
receptor), GFP (green fluorescent protein), HABA [2-(4-hydroxyphenylazo)benzoic acid], 
HEMA (2-hydroxyethyl methacrylate), LA (lactic acid), LbL (layer-by-layer), MAA 
(methacrylic acid), MBP (maltose binding protein), MNP (magnetic nanoparticle), MRI 
(magnetic resonance imaging), MWCNT	 (multi‐walled	 carbon	 nanotube),	 NHS (N-
hydroxysuccinimide), NP (nanoparticle), PACA [poly(alkyl cyanocrylate)], PAA [poly(acrylic 
acid)], PBD [poly(butadiene)], PCL [poly(ε-caprolactone)], PCN (polymer-caged nanobin), 
PDMA [poly(N,N-dimethylacrylamide)], PEG [poly(ethylene glycol)], PEI [poly(ethylene 
imine)], PEO [poly(ethylene oxide)], PET (position emission tomography), PGA (poly-L-
glutamic acid), PIC (polyion complex), PLL (poly-L-lysine), PMA [poly(methacrylate)], 
PMDETA (N,N,N',N',N"-pentamethyldiethylenetriamine), PMPC [poly(2-methyl-2-carboxyl-
propylene carbonate)], PNIPAM [poly (N-isopropylacrylamide)], PrMA (propyl methacrylate), 
PS [poly(styrene)], PTQY (photoluminescence quantum yield), PtNP (platinum nanoparticle), 
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PTMCC [poly(2-methyl-2-carboxytrimethylene carbonate)], PVP [poly(vinyl pyrrolidone)], QD 
(quantum dot), RAFT (reversible addition-fragmentation chain transfer), RGD (Arg-Gly-Asp), 
ROS (reactive oxygen species), SiNP (silica nanoparticle), SPAAC (strain-promoted azide-
alkyne cycloaddition), SPION (superparamagnetic iron oxide nanoparticle), STEM (scanning 
transmission electron microscopy), SWCNT (single-walled carbon nanotube), TBTA 
[tris(benzyltriazolylmethyl)amine], TCEP [tris(carboxyethyl)phosphine], TEC (thiol-ene 
coupling), THPTA [tris(hydroxypropyltriazolylmethyl)amine], TMS (trimethylsilyl), VNP (viral 
nanoparticle). 
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Abstract 
The purpose of this Expert Review is to discuss the impact of click chemistry in nanosized drug 
delivery systems. Since the introduction of the click concept by Sharpless and coworkers in 
2001, numerous examples of click reactions have been reported for the preparation and 
functionalization of polymeric micelles and nanoparticles, liposomes and polymersomes, 
capsules, microspheres, metal and silica nanoparticles, carbon nanotubes and fullerenes, or 
bionanoparticles. Among these click processes, the Cu(I)-catalyzed azide-alkyne cycloaddition 
(CuAAC) has attracted most attention based on its high orthogonality, reliability, and 
experimental simplicity for non-specialists. In addition, a renewed interest on the use of efficient 
classical transformations has been also observed (e.g., thiol-ene coupling, Michael addition, 
Diels-Alder). In this Expert Review special emphasis is also devoted to critically discuss the click 
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“The reaction must be modular, wide in scope, give very high yields, generate only 
inoffensive byproducts that can be removed by nonchromatographic methods, and be 
stereospecific (but not necessarily enantioselective). The required process characteristics 
include simple reaction conditions (ideally, the process should be insensitive to oxygen and 
water), readily available starting materials and reagents, the use of no solvent or a solvent that 
is benign (such as water) or easily removed, and simple product isolation. Purification - if 
required - must be by nonchromatographic methods, such as crystallization or distillation, and 
the product must be stable under physiological conditions… Click processes proceed rapidly to 
completion and also tend to be highly selective for a single product: we think of these reactions 
as being “spring-loaded” for a single trajectory”. H. C. Kolb, M. G. Finn and K. B. Sharpless. 
Angew. Chem., Int. Ed. 40: 2004-2021 (2001). 
 
INTRODUCTION 
Over the past few decades, various generations of drug delivery systems (DDS) have been 
developed for the controlled administration of drugs into the body (1). Among them, nanosized 
carriers are particularly attractive since they provide protection to the cargo, while enhancing 
cellular uptake and the selective delivery to specific cells. Since their appearance in the 1970s, a 
number of nanosized DDS have been described as carriers for the delivery and controlled release 
of drugs, including drug-polymer conjugates and nanoparticulate carriers, where the drug is 
either physically entrapped or covalently attached to the delivery system (2). 
The widespread application of DDS in nanomedicine has been prompted by several 
remarkable discoveries and breakthroughs, the most relevant being (1): (i) The aim of 
minimizing immunogenicity and preventing the early clearance of proteins, drugs, and DDS by 
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conjugation to hydrophilic biocompatible polymers, such as poly(ethylene glycol) (PEG) (3); (ii) 
The development of active targeting, that is the selective delivery of drugs to target tissues and 
cells facilitated by the privileged interaction of ligands on the periphery of drug carriers with cell 
surface receptors (4); (iii) The discovery of the enhanced permeability and retention (EPR) 
effect, also known as passive targeting to explain the selective accumulation of nanosized DDS 
within solid tumors thanks to fenestrations in the vasculature and a poor lymphatic clearance (5). 
Organic synthesis as a discipline has accompanied this evolution of drug delivery into a 
mature field by providing synthetic tools for the efficient bioconjugation of drugs, polymers, or 
targeting ligands, and the preparation of novel building blocks and polymeric materials for the 
construction of DDS with new properties (6). Indeed, chemistry is a central science where 
phenomena occur and properties are defined at the molecular level. The ability of putting 
together small building blocks into larger structures has been at the core of evolution and can be 
used to create novel properties and functions. The level of efficiency achieved by biological 
systems has inspired chemists in the search for more efficient processes with production of 
minimal waste. In this way, concepts such as atom economy (every atom of a reagent should be 
included in the product of the reaction), energy efficiency (the drive to reduce the energy 
requirements of chemical processes), catalysis (aimed to lower the energy input and avoid the 
use of stoichiometric reagents), step economy (the drive to reduce the number of synthetic steps), 
as well as safety and toxicity issues have been adopted in the search of more efficient and 
environmentally friendly procedures (green chemistry) (7). 
In this context, Sharpless and coworkers introduced in 2001 the concept of click chemistry 
(8), in an effort to focus the attention on the easy production of properties rather than on 
challenging structures. The idea is to confine the whole range of chemical transformations 
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available to a set of processes with a high thermodynamic driving force, allowing the efficient 
and easy transformation of "spring-loaded" starting materials into new substances with useful 
properties. 
This Expert Review covers the use of click procedures for the preparation and 
functionalization of nanoparticulate DDS. Rather than a comprehensive revision of the literature, 
a selection of -in our view- the most relevant examples reported in the area is presented 
following a historical perspective. The review begins with a description of the characteristics that 
define a reaction as click, and the evolution of those criteria when adapted to fields other than 
those originally considered by Sharpless and coworkers. A critical assessment on the tendency 
found in the literature to label as click many reactions that do not meet these requirements is also 
included. As the vast majority of the examples on the application of the click concept to drug 
delivery nanosystems rely on the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) (9),(10), 
the following section discusses the advantages and disadvantages of the use of CuAAC in 
bioconjugation. The need of a correct selection of catalyst, ligand, solvent, and experimental 
conditions to avoid degradation of the substrates under CuAAC conditions is also addressed. 
These features are of application not only to bioconjugation but to any other field. After these 
introductory sections, a selection of literature examples dealing with the use of click reactions 
[CuAAC, Michael addition, Diels-Alder, thiol-ene coupling (TEC), strain-promoted azide-alkyne 
cycloaddition (SPAAC)] for the preparation and functionalization of nanosized DDS is included. 
To facilitate reading, these examples have been organized according to the nature of the 
nanosystem: 
Polymeric Nano- and Microparticulate Delivery Systems 
Polymeric Micelles 
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Polymeric Nanoparticles (NP) 
Polymersomes and Liposomes 
Polymeric Capsules and Microspheres 
Metal and Silica Nanoparticles 
Gold (AuNP) and Noble-Metal Nanoparticles 
Magnetic Nanoparticles (MNP) 
Quantum Dots (QD) 
Silica Nanoparticles (SiNP) 
Carbon Nanotubes (CNT) and Fullerenes 
Bionanoparticles (BNP) 
Keeping in mind the multidisciplinarity of the drug delivery audience, it has been our 
intention to focus our attention not only on the chemical aspects of the click procedures, but also 
on the merits of the resulting DDS, paying special emphasis on their usefulness in therapy and 
diagnosis. Brief comments on the particular advantages of the conjugates produced, drugs being 
encapsulated, efficiency of the targeting processes, or the existence of in vivo or in vitro assays 
are also commented. In a complementary following-up review, we will discuss on the use of 
click chemistry for drug delivery applications with synthetic polymers, dendrimers, and 
biopolymers. 
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THE CONCEPT OF CLICK CHEMISTRY 
In 2001, Sharpless and coworkers introduced the concept of click chemistry in the field of 
drug discovery (8). In an effort to focus the attention on the easy production of properties rather 
than on challenging structures, these authors suggested that: "all searches (of drug candidates) 
must be restricted to molecules that are easy to make". This strategy was designed to enable the 
straightforward and economic synthesis of large libraries of new compounds with a minimum 
synthetic cost. With this aim, it was proposed to confine the whole range of possible chemical 
transformations to a set of processes with a high thermodynamic driving force (usually higher 
than 20 Kcalꞏmol-1), which could allow the efficient transformation of "spring-loaded" starting 
materials into new substances with useful biological properties. In addition, among the highly 
energetic starting materials available, "those provided by Nature, petroleum chemistry, or easily 
manufactured from any of those" were selected, being olefins and acetylenes the preferred 
candidates. 
Besides being highly exothermic processes, click reactions should be also characterized by 
a high orthogonality. This means that coupling partners in click processes should have a wide 
functional group tolerance, but selectively react to each other under a broad range of 
experimental conditions. In this way, the need of protecting groups is avoided. Thanks to these 
intrinsic characteristics, reactivity and orthogonality, click processes are reliable and clean 
transformations of broad scope, that proceed in quantitative (or near-quantitative) yields, where 
simple or no purifications are required. 
In order to provide an adequate toolbox of chemical transformations, a set of stringent 
criteria was established for a process to be considered as click (8): "(to) be modular, wide in 
scope, give very high yields, generate only inoffensive byproducts that can be removed by 
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nonchromatographic methods, and be stereospecific (but not necessarily enantioselective). The 
required process characteristics include simple reaction conditions (ideally, the process should 
be insensitive to oxygen and water), readily available starting materials and reagents, the use of 
no solvent or a solvent that is benign (such as water) or easily removed, and simple product 
isolation. Purification -if required- must be by nonchromatographic methods, such as 
crystallization or distillation, and the product must be stable under physiological conditions". 
These very stringent criteria are actually fulfilled only by a narrow set of chemical 
transformations, mainly comprising carbon-heteroatom bond forming reactions. Four main 
groups were originally defined on these basis (8): (i) additions to carbon-carbon multiple bonds 
(such as epoxidation, dihydroxylation, aziridination, sulfenyl halide addition, and Michael 
addition chemistry), (ii) nucleophilic substitution chemistry (such as ring-opening reactions of 
strained cycles, e.g., epoxides, aziridines, aziridinium ions, and episulfonium ions), (iii) 
cycloadditions of unsaturated species (such as 1,3-dipolar cycloadditions and Diels-Alder 
reactions), and (iv) carbonyl chemistry of the "non-aldol" type (such as formation of ureas, 
thioureas, aromatic heterocycles, oxime ethers, hydrazones, and amides). The potential of these 
four groups of click reactions for the efficient preparation of complex structures has been 
highlighted by Sharpless and coworkers in short synthetic sequences as seen in Fig. 1. 
Interestingly, it is worth to point out that although the concept of click chemistry has emerged 
recently, it essentially relies on classical chemical transformations, and therefore, publications 
appearing before the click era (and hence not labeled as click) should be taken into account in 
this context. An illustrative example is the century-old photochemically/thermally induced 
radical addition of thiols to alkenes (i.e., thiol-ene coupling, TEC), which has now reappeared as 
the thio-click reaction. 
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Fig. 1  
Among the click reactions proposed so far, the Cu(I)-catalyzed cycloaddition of azides and 
terminal alkynes (CuAAC) has attracted special interest (Fig. 2). Independently reported by the 
groups of Meldal (9), and Fokin and Sharpless (10), this reaction displays one of the greatest 
orthogonaties ever seen. As opposed to the classical thermal Huisgen 1,3-dipolar azide-alkyne 
cycloaddition (AAC), where high temperatures (ca. 100 ºC) and long reaction times are typically 
required, the Cu(I) catalysis significantly reduces the activation barrier, allowing the reaction to 
proceed with very good rates at room temperature, both in aqueous media and organic solvents 
(Fig. 2). Moreover, the CuAAC is regioespecific, leading exclusively to 1,4-disusbstituited 1,2,3-
triazoles, whereas mixtures of regioisomers are obtained under non-catalyzed conditions. In 
addition, the ease with which azide and alkyne moieties are introduced both chemically 
(nucleophilic substitution, diazo transfer, incorporated into low molecular weight tags) and 
biologically (incorporating acetylene and azido amino acids into proteins in either a residue-
specific or site-specific fashion) (11), along with their small size and exceptional stability in 
complex environments, have allowed their incorporation into a vast range of substrates as 
handles with hidden reactivity. All these features justify CuAAC at the leading edge within the 
click reports. 
Fig. 2 
Since click chemistry was originally defined by Sharpless and coworkers, an ever 
increasing number of publications dealing with its application to different areas of research have 
quickly appeared in the literature. Fields such as polymer and materials science, medicinal 
chemistry, chemical biology, and the pharmaceutical sciences, among others, have clearly 
profited from the click concept (12),(13),(14),(15). However, in spite of this favorable reception, 
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a survey of the literature reveals that in many publications, even entitled as "click", some of the 
fundamental concepts of click chemistry are being misinterpreted. For instance, the use of 
heating to accelerate the reaction rate has been branded by different authors as against the 
"simple reaction conditions" requirement. Actually, it should be emphasized that click reactions 
are generally characterized by having high activation energies, and therefore, they are often 
performed by heating (8) (Fig. 1). The use of organic solvents has also been controversial, as 
sometimes it has been stated that click reactions are only allowed to be performed in water, 
aqueous mixtures, or neat. In this sense, while water is often the preferred reaction medium, 
organic solvents can be also used as nicely illustrated by Sharpless and coworkers in their 
seminal report (Fig. 1) (8). 
On the other hand, given the original application of click chemistry to drug discovery, it is 
clear that the stringent criteria for a click process might be revised when adapted to other fields. 
This adjustment, however, must be in agreement with the click philosophy. For instance, while 
stereospecificity is demanded for drug discovery, it may not be important for delivery purposes, 
or in polymer and materials science. In a similar way, substrates such as many DDS cannot be 
considered as "readily available starting materials", as several steps of "non-click" type 
chemistry are frequently required for their preparation. 
However, besides these particular adjustments, some key requirements of click chemistry 
are sometimes being severely distorted in papers claimed as click. A good example is the use of 
chromatographic purifications that clearly violates the click philosophy, and could be only 
accepted when dealing with macromolecular structures that are difficult to purify by the typical 
techniques demanded of low molecular weight compounds (e.g, crystallization or distillation). 
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To sum up, in spite CuAAC being considered as "the cream of the crop" among the click 
reactions, not every single process relying on CuAAC necessarily fulfills the click requisites. In 
other words, mixing an azide and an alkyne in the presence of Cu(I) does not necessarily imply a 
click process if accompanied, for instance, by low yields or tedious chromatographic 
purifications. Moreover, experimental conditions such as catalyst loading, ratio of reagents, and 
formation of byproducts should also be considered in evaluating the overall efficiency and 
convenience of the process. 
Finally, we would like to highlight that the high impact of the click concept in chemistry 
and other disciplines has sometimes derived in an abusive use of the term click. For instance, a 
number of reactions that strongly defy the click philosophy have been proposed as new examples 
of click reactions. On the other hand, well-known and established reactions are now being 
"relabeled" with the fashionable click tag (e.g., thio-click coupling, thio-bromo click, or Diels-
Alder click reactions). In addition, the relevance of CuAAC among the click reactions has 
sometimes led to label this as "the click reaction", obviating all other processes fulfilling the 
click criteria. Readers must be aware of the above considerations and, in order to avoid 
misinterpretations, critical reading is advised. 
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BIOCONJUGATION VIA HUISGEN AZIDE-ALKYNE CYCLOADDITIONS 
Bioconjugation techniques play an important role in drug delivery. The conjugation of 
peptides, antibodies, or aptamers on the surface of DDS allows their active targeting to specific 
cells and organs. In addition, the coupling of synthetic polymers to biomolecules has been 
described as a method to improve their pharmacokinetics and to increase their stability. Other 
interesting applications of bioconjugation deal with the labeling of biomacromolecular 
therapeutics such as proteins and nucleic acids, with tags for in vivo imaging purposes. With the 
aim of preserving the structural and functional integrity of biomolecules, bioconjugation 
processes should be ideally performed with fast kinetics, and under mild conditions in aqueous 
media. 
Thanks to its high orthogonality, reliability, and experimental simplicity for non-
specialists, it is not surprising that CuAAC quickly found application in the bioconjugation arena 
soon after being described in the literature. Unfortunately however, the use of CuAAC in 
bioconjugation has not been a straightforward task. Thus, the required Cu(I) catalyst has been 
demonstrated to induce severe structural damage to biomolecules. Also, under the original 
conditions reported by Fokin, Sharpless, and coworkers (CuSO4/sodium ascorbate) (8), CuAAC 
often lacks adequate kinetics at the micromolar range typically employed in bioconjugation. 
Taking into account the relevance of CuAAC within click chemistry, it is the intention of this 
section to analyze the encountered problems and proposed solutions for the efficient and 
harmless conjugation of biomolecules via CuAAC. 
Some of the limitations of CuAAC in bioconjugation were soon pointed out by Fokin, 
Sharpless, Finn, and coworkers who described that cowpea mosaic virus (CPMV) resulted either 
degraded or aggregated in the presence of Cu and the reducing agents used for the in situ 
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generation of Cu(I) (16). Indeed, the role of Cu in the oxidative stress of biomolecules is well-
known. Cu ions can easily promote the generation of reactive oxygen species (ROS), such as 
H2O2, and the hydroxyl (•OH) and superoxide (O2•-) radicals, which are responsible of biological 
damage (17). The production of •OH, the most powerful ROS species, is mediated by a Fenton 
reaction involving a transition metal, Cu(I) in this case, and H2O2 (eq 1) (18). The required H2O2 
is formed in situ via two possible mechanisms: (i) in the presence of ascorbate (AH2), O2 can be 
reduced to H2O2 in a process catalyzed by traces of Cu(II) or other transition metal ions (eq 2) 
(18); (ii) in the absence of ascorbate or other reducing agents, Cu(I) itself can reduce O2 to H2O2 
through a two-step process involving the mediation of O2•- (eq 3,4) (17). The presence of ROS 
during the functionalization of biomolecules, such as proteins, nucleic acids, polysaccharides, 
and lipids is therefore a major concern, as the structural and functional integrity of these 
substrates might result severely compromised. 
Cu(I) + H2O2  Cu(II) + •OH + OH- (1) 
AH2 + O2  A + H2O2 (2) 
Cu(I) + O2 O2•- + Cu(II) (3) 
Cu(I) + O2•-+ 2H+  Cu(II) + H2O2 (4) 
Other undesired reactions, such as the homocoupli 
ng of terminal alkynes through Cu(I)-catalyzed Glaser reaction, have been also observed 
under CuAAC conditions (19). Altogether, these secondary processes diminish the efficiency of 
the conjugation, and are particularly undesired in the functionalization of macromolecular 
platforms, as purifications are often eventually impossible. 
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In a general sense, the aforementioned drawbacks of CuAAC can be efficiently overcome 
with the proper selection of the catalytic system, which usually requires the use of a Cu(I)-
chelating ligand (20),(21). These ligands are designed to: (i) stabilize the Cu(I) oxidation state, 
(ii) accelerate the cycloaddition reaction, (iii) prevent the formation of undesired byproducts, and 
(iv) sequester Cu ions to reduce the structural damage to biomolecules and to facilitate the 
purification process. In this regard, tris(benzyltriazolylmethyl)amine (TBTA) (20), 
tris(hydroxypropyltriazolylmethyl)amine (THPTA) (20), and bathophenanthroline disulphonated 
disodium salt (BPDS) (21) have been the ligands most usually employed in bioconjugation (Fig. 
3). 
Fig. 3 
The tetradentate binding ability of tris(triazolylmethyl)amine ligands allows the formation 
of stable Cu(I) chelates that account for an increase of ca. 300 mV in the redox potential of 
Cu(I)/Cu(II) (20). TBTA was the first member of this family to be identified. The superior 
protection conferred by TBTA to Cu(I) towards air oxidation renders unnecessary the exclusion 
of O2 from the reaction medium. Nevertheless, a great shortcoming of TBTA is its poor 
solubility in water, which has fuelled the development of water-soluble analogs, such as THPTA 
(22). In addition, partly because of this poor water solubility, the typical rate enhancement of 
TBTA has been claimed as low, with kinetics comparable to other classical bioconjugation 
reactions. 
BPDS represents an attractive alternative to tris(triazolylmethyl)amine ligands. It exhibits a 
high solubility in water and an excellent catalytic activity, even under high dilution conditions or 
when working with small excess of coupling probes (23). Conversely, the BPDS/Cu(I) catalytic 
system has revealed very sensitive to air oxidation, and unless a sacrificial reducing agent is 
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added, the rigorous exclusion of O2 from the reaction medium is required to avoid oxidation of 
Cu(I). 
A survey of the literature reveals many examples to illustrate that the correct selection of 
the catalytic system allows CuAAC to become a safe and efficient tool in bioconjugation. 
However, despite the use of Cu(I)-chelating ligands, a loss of bioactivity/integrity of proteins and 
nucleic acids during CuAAC bioconjugation has been reported in several cases (24), which 
highlight the necessity of more convenient CuAAC protocols. To this end, Finn and coworkers 
have reported an electrochemically protected version of the CuAAC, where Cu(II) is 
electrochemically reduced to Cu(I) in the presence of the desired accelerating ligand (25) (Fig. 
4). In this way, the oxidation state of Cu(I) is continuously preserved without the addition of any 
sacrificial reducing agent. In addition, oxidative degradation of substrates by ROS is drastically 
diminished, as the O2 present in the reaction medium, which is necessary for the generation of 
ROS (eq 1-4), is electrochemically reduced to H2O (i.e., O2 + 4H+ + 4e-  2H2O). In a more 
recent report, this group has proposed a bioconjugation protocol relying on the simplicity of the 
Cu(II)/ascorbate system and the use of THPTA (22) (Fig. 4). Besides the typical ligand-
accelerating effect, THPTA was found to mediate the decomposition of H2O2 produced in the 
reaction medium and to act as a radical scavenger. As previously pointed out by Brown and 
coworkers (26), a 5-fold excess of THPTA vs Cu(I) was recommended to minimize the oxidative 
degradation of substrates. The addition of aminoguanidine as carbonyl capturing reagent was 
also recommended to preserve substrates from reaction with ascorbate and other byproducts 
derived from ascorbate oxidation (Fig. 4). 
Fig. 4 
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Alternatively, more benign Cu-free AAC bioconjugation strategies, not requiring the 
addition of cytotoxic metals and additives, have also appeared. The group of Bertozzi has taken 
advantage of the inherent ring strain of cyclooctynes as an effective way for lowering the 
activation barrier of AAC (24) (Fig. 5). This strain-promoted AAC variant named as SPAAC has 
found widespread application in the context of the bioorthogonal chemical reporter strategy for 
the study of dynamic processes of biomolecules. In addition, SPAAC has recently gained 
significance in polymer/materials science and drug delivery applications, where the presence of 
Cu prevents the use of CuAAC (27),(11). Rate optimization of SPAAC for faster bioconjugation 
under mild conditions has been reported by the groups of Bertozzi, Boons, and van Hest and van 
Delft, by means of difluorocyclooctyne (DIFO) (28),(29), dibenzocyclooctyne (DIBO) (30), 
dibenzoazacyclooctyne (DIBAC) (31), biarylazacyclooctynone (BARAC) (32), and 
bicyclononyne (BCN) (33) derivatives (Fig. 5). The higher reactivity of these reagents compared 
to unfunctionalized cyclooctyne relates to the presence of electron-withdrawing groups and 
increased ring strain, which have afforded reaction rate values comparable to those of ligand-less 
CuAAC. Interestingly, a cyclooctyne precursor of the reactive DIBO with the triple bond masked 
as cyclopropenone has been developed by Boons, Popik, and coworkers for the photo-triggering 
of SPAAC under UV irradiation (ca. 350 nm) (34) (Fig. 5). 
Fig. 5 
It must be pointed out that although the use of cyclooctynes hampers SPAAC to qualify as 
a pure click reaction as originally defined (lack of regioselectivity and no readily available 
starting materials), it essentially matches the click philosophy when dealing with 
macromolecular structures as those in drug delivery applications. 
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POLYMERIC NANO- AND MICROPARTICULATE DELIVERY SYSTEMS 
Over the past few decades, there has been considerable interest in the use of delivery 
systems for the safe and efficient administration of drugs (1). With this aim, various polymeric 
nano- and microparticulate systems have been described, including polymeric micelles and NP, 
polymersomes, and polymeric capsules and microspheres (2). These DDS have been reported to 
effectively deliver drugs to target sites and hence to increase the therapeutic index, while 
reducing undesirable side effects and the frequency of administration. In particular, DDS can 
enhance the therapeutic activity by prolonging the drug half-life, improving the solubility of 
hydrophobic drugs, reducing the immunogenicity, and allowing a sustained or stimuli-triggered 
release of drugs (1),(35). In this section the use of click chemistries for the preparation and 




Polymeric micelles are spherical nanostructures usually obtained by self-assembly of 
amphiphilic block copolymers in water, that are considered as promising drug carriers (36). They 
are characterized by a size in the range 20-100 nm (similar to that of lipoproteins and viruses) 
and a core-shell structure consisting of a hydrophobic core surrounded by a hydrophilic shell. 
While the core provides a potential reservoir for hydrophobic drugs, the hydrophilic shell ensures 
low protein adsorption, improved drug solubility, and long circulation times in the blood stream. 
This stealth property, along with their characteristic small sizes, allow the selective accumulation 
of polymeric micelles in tumor tissues due to the known EPR effect (5). 
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Various click reactions, especially CuAAC, have been used in either the preparation of 
block copolymers that self-assemble into micelles, or in the surface functionalization of 
polymeric micelles. As an example of the first category, Sumerlin and coworkers used CuAAC 
for the functionalization of a temperature-responsive block copolymer with folic acid (FA) (37). 
A thermoresponsive azido-terminated poly(N,N-dimethylacrylamide)-b-poly(N-
isopropylacrylamide) (N3-PDMA-b-PNIPAM) was synthesized by reversible addition-
fragmentation chain transfer (RAFT) polymerization using an azido-functionalized chain transfer 
agent (CTA), NIPAM and DMA, which was subsequently decorated with a propargyl folate by 
CuAAC (CuBr, PMDETA, DMF). The resulting block copolymer underwent self-assembly to 
yield polymeric micelles of approximately 46 nm at 34 ºC, as potential drug delivery systems 
with active-targeting for cancer tissues. 
Following a similar approach, the groups of Li (38) and Stenzel (39) independently 
prepared block copolymers incorporating pendant azides/alkenes in one of the blocks that were 
subsequently functionalized with carbohydrates by means of CuAAC and TEC to give 
amphiphilic block copolymers. Li and coworkers prepared a series of biodegradable 
glycopolymers based on poly(ε-caprolactone) (PCL). PCL-b-PBrCL was synthesized by ring-
opening polymerization and then, the bromine groups were transformed into azides and 
subsequently functionalized with alkynyl saccharides via CuAAC (CuBr, PMDETA, DMF) to 
give amphiphilic block copolymers that self-assembled into micellar aggregates (38). 
Taking advantage of TEC, Stenzel and coworkers prepared glycomicelles as potential drug 
carriers. A block copolymer containing di(ethylene glycol) methyl ether methacrylate and 2-
hydroxyethyl methacrylate (HEMA) was prepared by RAFT polymerization, and further 
modified with glucothiose via alkene incorporation and TEC (UV light, 2,2-dimethoxy-2-phenyl 
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acetophenone, DMF). The resulting glycosylated block copolymer led to the formation of 
thermoresponsive micelles (39) (Fig. 6). 
Fig. 6 
Several interesting examples on the use of CuAAC for the preparation of PEG-dendritic 
block copolymer-based micelles and other nanostructures have been reported by the group of 
Dong (40, 41, 42). For instance, they prepared spherical flower-like micelles of ca. 50 nm by 
self-assembly in aqueous solution of dendron-like PCL-b-PEG-b-dendron-like PCL triblock 
copolymers prepared by CuAAC (CuBr, PMDETA, DMF) (Fig. 7). These micelles were able to 
encapsulate the anticancer drug doxorubicin (DOX) with high loading efficiency, and displayed 
a sustained release profile. 
Fig. 7 
Recently, Kakkar, Maysinger, and coworkers reported the preparation of miktoarm 
micelles as nanocarriers for nimodipine, a hydrophobic drug employed in the prevention and 
treatment of delayed ischemic neurological disorders (43). In their approach, miktoarm A2B 
polymers (A = PEG, B = PCL) were constructed from a core containing one hydroxyl and two 
alkynyl groups, which allowed the incorporatiom of two PEG-N3 chains by CuAAC (CuBr, 
PMDETA, degassed DMF), followed by ring-opening polymerization of ε-caprolactone. After 
self-assembly of the miktoarm polymers into spherical micelles, nimodipine was loaded with 
high encapsulation efficiency. In vitro studies revealed a slow release which results 
advantageous in order to reduce the frequency of administration and toxicity. 
Zhang and coworkers have also employed CuAAC for the preparation of core-shell 
micelles with tumor-triggered targeting properties (44) (Fig. 8). In their approach, an azido-
modified -cyclodextrin (CD), designed to act as a host for the terminal phenyl group at the 
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hydrophilic polymer P(NIPAM-co-N-acroyloxysuccinimide), was coupled via CuAAC (CuSO4, 
sodium ascorbate, PMDETA) to an alkynated -CD, designed to complex hydrophobic PCL 
bearing a terminal adamantyl group. The CD dimer was used to connect the hydrophilic and 
hydrophobic segments that subsequently assembled. The resulting micelles were further 
functionalized with an Arg-Gly-Asp (RGD) peptide as targeting ligand to improve the cellular 
uptake efficacy. PEGylation via pH-sensitive imine bonds was employed to protect the peptide 
ligands in normal tissues and body fluids. In addition, DOX was loaded into the micelles and two 
dyes were conjugated to the polymer components to track the formation of the micelles. The 
authors demonstrated that the targeting property of the micelles was switched on only after 
removing the PEG segment at the tumor site, which also triggered the release of DOX by 
decreasing the lower critical solution temperature of the micelles. 
Fig. 8 
CuAAC has also been employed for the surface functionalization of polymeric micelles. In 
one of the first examples, reported by Lutz and coworkers, the in situ shell-functionalization of 
biocompatible micelles with a hydrophobic core and a PEG-based corona was described (45). 
Surfactants composed of a hydrophobic cholesterol moiety and a hydrophilic polymer segment 
were synthesized from various oligo(ethylene glycol) methacrylates by atom transfer radical 
polymerization (ATRP), initiated by cholesteryl-2-bromoisobutyrate. After polymerization, the 
bromine chain-ends were transformed into azides. Some of the resulting polymers formed 
thermoresponsive micellar aggregates (ca. 100 nm) in aqueous solution that could be decorated 
with propargyl alcohol as a model ligand by CuAAC (CuSO4, sodium ascorbate). 
Poly(alkyl cyanocrylate) (PACA) is a biodegradable polymer well-known in the 
pharmaceutical field, that has been developed for more than two decades by the group of 
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Couvreur for the preparation of different drug delivery nanostructures (46). Nicolas and 
coworkers have recently reported the preparation of clickable PEGylated PACA micelles from a 
poly[(hexadecyl cyanoacrylate)-co-azidopoly(ethylene glycol) cyanoacrylate] copolymer, 
displaying azide functionalities at the end of the PEG chains (47) (Fig. 9). CuAAC 
functionalization was either performed directly on the polymer (CuBr, PMDETA, DMF) 
followed by self-assembly in aqueous solution, or alternatively onto the surface of preformed 
micelles in aqueous media (CuSO4, sodium ascorbate). This versatile approach opens the door to 
ligand-functionalized biodegradable PACA micelles with stealth properties for biomedical 
applications. 
Fig. 9 
The delivery of ophthalmic drugs using polymeric micelles with targeting RGD peptides is 
a promising tool for the treatment of a wide range of corneal epithelial defects. With this aim, 
Shoichet and coworkers have designed peptide-modified micelles by taking advantage of a 
CuAAC surface decoration (48). An amphiphilic block copolymer was prepared from poly(2-
methyl-2-carboxytrimethylene carbonate-co-D,L-lactide) [P(TMCC-co-LA)] and an amine-
terminated PEG-N3. The resulting P(TMCC-co-LA)-g-PEG-N3 copolymer self-assembled in 
aqueous solution and the azide groups on the surface of the micelles were functionalized with 
alkyne-modified KGRGDS peptides via CuAAC in water (CuSO4, sodium ascorbate). The 
covalently bound RGD peptides maintained their bioactivity and binding affinity towards rabbit 
corneal epithelial cells. 
The group of Shoichet has also described an elegant route to immuno-polymeric micelles 
based on Diels-Alder cycloaddition (49) (Fig. 10). An amphiphilic P(TMCC-co-LA)-g-PEG-
furan carrying furan as a terminal diene was prepared and self-assembled. The furan groups on 
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the outer PEG shell were then reacted with a maleimide-modified anti-HER2, a therapeutic 
antibody used to treat breast cancer. Under these mild conditions, the classical low efficiency and 
loss of activity associated with the coupling of sensitive antibodies were overcome. In addition, 
the procedure takes advantage of the increased reaction rate and stereoselectivity of Diels-Alder 
couplings in aqueous media. The anti-HER2 immuno-micelles specifically bound to HER2-
overexpressing cells, demonstrating the strength of this procedure to create bioactive immuno-
micelles. As only a few anti-HER2 antibodies on the surface of the micelles were necessary for 
targeting, thousands of PEG-furan chains were available for coupling to a DOX-maleimide 
conjugate in a subsequent step (50). The resulting DOX-conjugated immuno-micelles represent 
an entirely new method for localized codelivery of chemotherapeutics and antibodies. 
Fig. 10 
The Michael addition of thiols to activated olefins has been successfully applied to the 
functionalization of micelles. In an interesting example, the groups of An and Stucky have 
reported a combination of Michael addition and CuAAC for the orthogonal functionalization of 
the core and shell of polymeric micelles (51) (Fig. 11). Monodisperse core-shell micelles (65-95 
nm) were prepared by a RAFT-mediated precipitation polymerization of NIPAM, using a 
preformed PDMA RAFT polymer as CTA. The PNIPAM generated during the process 
constituted the core in which trithiocarbonate groups were located, while PDMA blocks carrying 
azido groups formed the shell on the surface. The core of the micelle could be functionalized 
with a fluorescein o-acrylate through a one-pot aminolisis/Michael addition, while the shell was 
decorated with a dansyl probe via CuAAC (CuSO4, sodium ascorbate, DMF-H2O). 
Fig. 11 
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The group of Nguyen has shown that drug-containing (indomethacin or DOX) amphiphilic 
polynorbornenes can self-assemble into therapeutically active core-shell polymer micelles with 
uniform, tunable diameters (52),(53). More recently, the same group has reported a CuAAC 
strategy for the functionalization of these micelles with various bioactive ligands/particles (54). 
An indomethacin-containing norbornene monomer and a trimethylsilyl (TMS) protected 
acetylene-terminated hydrophilic hexa(ethylene) glycol norbornene monomer were sequentially 
polymerized in different ratios by ring-opening metathesis polymerization. After deprotection of 
the TMS groups, block copolymers self-assembled in water into alkyne-decorated NP that were 
decorated by CuAAC (CuSO4, sodium ascorbate) with azido-functionalized folate, biotin, or 
AuNP. 
Jing, Chen, and coworkers have reported on the surface functionalization of microspheres 
(55) and biodegradable polymer fibers (56) with proteins and antibodies by means of CuAAC. In 
a recent paper, an artificial oxygen carrier was constructed by conjugating hemoglobin to 
biodegradable micelles (57) (Fig. 12). The authors prepared a series of triblock copolymers from 
PLA, poly(2-methyl-2-carboxyl-propylene carbonate) (PMPC), and PEG, carrying pendant 
propargyl groups at the PMPC middle block. These amphiphilic copolymers self-assembled in 
aqueous solution into core-shell micelles. Hemoglobin containing azide groups was conjugated 
via CuAAC (CuSO4, sodium ascorbate, histidine) to the propargyl groups on the core surface, a 
privileged location to facilitate coupling while ensuring protection of the protein against the 
immunological system by the PEG corona. The hemoglobin content and the oxygen binding 
ability of the micelles were studied, revealing a maximum hemoglobin loading of 70 wt% and 
retention of its oxygen-binding ability. 
Fig. 12 
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Quite similarly, Liu, Zhao, and coworkers reported the preparation of an azido-containing 
amphiphilic triblock copolymer PEG-b-poly(azidoethyl methacrylate)-b-poly(methyl 
methacrylate) that in aqueous media self-assembled into spherical micelles carrying azide groups 
at the hydrophobic/hydrophilic interface. The conjugation of biotin via CuAAC (CuSO4, sodium 
ascorbate, t-BuOH-H2O) resulted in the formation of a functional interface between the 
hydrophilic shell and the hydrophobic core with demonstrated bioavailability (58). 
An interesting family of polymeric micelles is the so-called Polyion Complex (PIC). 
Originally described by the groups of Kataoka (59) and Kabanov (60), PIC micelles are formed 
by electrostatic interaction between oppositely charged polymers. Their electrical neutrality, 
small size, and fairly narrow size distribution makes them very appealing for drug delivery 
purposes. The group of Fernandez-Megia and Riguera recently described the CuAAC (CuSO4, 
sodium ascorbate, t-BuOH-H2O) functionalization of PEG-dendritic block copolymers of the 
GATG (gallic acid-triethylene glycol) family with peripheral anionic groups. One of the 
copolymers carrying 27 peripheral sulphates led to PIC micelles of ca. 25 nm by incubation with 
poly-L-lysine (PLL) (Fig. 13). These micelles resulted to be remarkably stable under 
physiological conditions (150 mM NaCl, 37 ºC), high ionic strengths, and even freeze drying-
resuspension, as a result of an increased stability granted by the dendritic scaffold (61). 
Fig. 13 
Liu and coworkers have recently reported another example of CuAAC in the preparation of 
PIC micelles (62). A combination of ATRP and CuAAC (CuBr, DMF) was used to obtain two 
oppositely charged graft ionomers: PNIPAM-grafted poly[methacrylic acid-co-(3-azidopropyl 
methacrylate)] [P(MAA-co-N3PrMA)], and PNIPAM-grafted poly{[2-
(trimethylammonium)ethyl methacrylate]-co-N3PrMA}. The incubation of both ionomers in 
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aqueous solution led to the formation of PIC micelles with thermoresponsive PNIPAM coronas. 
In a further step, CuAAC (CuSO4, sodium ascorbate) was used again to cross-link the core of the 
micelles, following a strategy previously reported by the groups of Wooley and Hawker (vide 
infra), to ensure their stability against ionic strength and pH changes. 
 
Polymeric Nanoparticles 
In spite of the favorable features of polymeric micelles for drug delivery applications, these 
assemblies may suffer from spontaneous dissociation at concentrations below their critical 
micelle concentration (CMC), and from low stability at high temperatures (and ionic strengths in 
the case of PIC micelles). A common strategy to confer greater stability to these self-assembled 
structures is the cross-linking of the individual core/shell components to give core cross-linked 
or shell cross-linked NP (63, 64). Wooley, Hawker, and coworkers described the first 
applications of CuAAC in this field in a series of very exciting contributions (65),(66). In their 
first report, an amphiphilic diblock copolymer, poly(acrylic acid)-b-poly(styrene) (PAA-b-PS), 
that had been assembled into micelles and partially functionalized throughout the corona with 
alkynyl groups, was shell cross-linked with a first generation azido-terminated dendrimer by 
CuAAC (CuSO4, sodium ascorbate) (65) (Fig. 14). The resulting NP benefited from increased 
stability and the presence of imbedded azides into the shell for further functionalization. The 
complementary approach for the preparation of well-defined core cross-linked polymeric NP was 
realized from an amphiphilic diblock copolymer PAA-b-PS, containing alkynyl groups partially 
incorporated throughout the hydrophobic PS block (66). 
Fig. 14. 
Lallana Page 28 
Click Chemistry for Drug Delivery Nanosystems 
Stabilization of block copolymer micelles following similar CuAAC cross-linking 
approaches has been extensively investigated by different groups in the last few years. For 
instance, Liu and coworkers described the preparation of core cross-linked NP with 
thermoresponsive cores from PDMA-b-P(NIPAM-co-azido-propylacrylamide) (67). The same 
authors in collaboration with the group of Narain have reported the fabrication of two cross-
linked micelles with inverted structures from a single water-soluble triblock copolymer 
composed by poly[2-(2-methoxyethoxy)ethyl methacrylate], PDMA, and poly[2-
(diethylamino)ethyl methacrylate] blocks (68). 
An interesting application of this cross-linking strategy has been developed by Stenzel´s 
group for the preparation of carriers for the delivery of cobalt pharmaceuticals (69). A core-shell 
micelle was prepared by self-assembly of a poly(trimethylsilyl propargyl methacrylate)-b-
poly[poly(ethylene glycol) methyl ether methacrylate] obtained by RAFT polymerization, after 
removal of the TMS protecting groups. Then, the pendant alkyne groups at the core were use as 
reactive functional groups for cross-linking via CuAAC (Cu wire, Cu(PPh3)3Br, DIPEA, THF-
H2O), and as ligands for Co2(CO)8 to generate a macromolecular carrier of the antitumor agents 
based on (alkyne)Co2(CO)6. It is worth to note that while Co-loaded micelles resulted highly 
toxic to L929 fibroblast cells, the permanent encapsulation of the Co complex in the cross-linked 
NP was shown to reduce the toxicity. 
Click procedures have been applied not only to the covalent cross-linking of micelles, but 
also to the surface decoration of NP. In this regard, the group of Fernandez-Megia and Riguera 
has described the use of SPAAC as an efficient alternative to CuAAC for the orthogonal 
functionalization of polymeric NP, that avoids the detrimental effects associated to the Cu(I) 
catalyst (70) (Fig. 15). In their work towards the CuAAC functionalization of chitosan-g-PEG-N3 
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NP as carriers across the blood-brain barrier, a severe oxidative depolymerization of the chitosan 
backbone mediated by •OH was observed, along with high contents of cytotoxic Cu severely 
compromising their biomedical applications. These detrimental effects, seen also in other 
polysaccharides (e.g., dextran and hyaluronic acid), led the authors to explore the use of SPAAC 
as a safer Cu-free coupling technology. In this way, the surface functionalization of cross-linked 
chitosan-g-PEG-N3 NP with a cyclooctyne-derived anti-BSA antibody proceeded safely and 
quantitatively under physiological conditions, in what represents a step forward in the 




Polymersomes and Liposomes 
Liposomes are self-closed vesicular structures composed of (phospho)lipid bilayers that 
have attracted considerable attention in drug/gene delivery and diagnosis, and have reached 
clinical application especially for the treatment of cancer and opportunistic diseases (71). 
Although liposomes are not polymeric DDS, they are included in this section due to their 
relevance in drug delivery and their similarity to polymersomes. 
The functionalization of the surface of liposomes with different ligands to target specific 
cells has been traditionally performed by means of active esters, Michael additions, or 
hydrazones. The first example on the use of CuAAC with this purpose was reported by the group 
of Schuber (CuSO4, sodium ascorbate, BPDS) who prepared mannosylated vesicles from 
liposomes incorporating a synthetic lipid carrying a terminal alkyne (72). Interestingly, the use 
BPDS as Cu(I)-chelating ligand (2-fold excess over Cu) allowed a large increase in the yield of 
mannosylation and a decrease in the reaction time. In a similar manner, Kros and coworkers 
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described the surface functionalization of liposomes with a fluorescent probe (73). By means of 
fluorescence resonance energy transfer (FRET) studies, these authors revealed that the CuAAC 
functionalization occurred on the liposome surface. More recently, Cai and coworkers optimized 
the CuAAC conditions for the functionalization of liposomes (74). These authors prepared 
physically robust clickable polymerized liposomes based on polydiacetylene lipids that were 
efficiently decorated with multiple functionalities (FITC, coumarin, and a GRGD peptide) 
without decomposition of the liposomes, a feature usually observed for unsaturated liposomes 
under CuAAC conditions. The improved reaction conditions are based on the use of a Cu(I)-
chelating ligand [a tris(triazolylmethyl)amine derivative bearing tetra(ethylenglycol) side chains] 
that is highly soluble in water, insensitive to air, and has shown to shorten reaction times with 
reduced amounts of CuSO4 and sodium ascorbate. 
Similarly to liposomes, polymersomes have attracted a great deal of attention in the field of 
drug delivery. They are hollow vesicles characterized by a bilayer membrane built from 
amphiphilic block copolymers that have many similarities to liposomes, but a greater stability 
(lower CMC values) and decreased permeability. Since they were reported by the group of 
Discher and Hammer (75), polymersomes have been the subject of intensive research with 
applications ranging from imaging agents and delivery vehicles to nanoreactors (76). 
The first application of CuAAC to the functionalization of polymersomes was reported by 
the group of van Hest (77) (Fig. 16). These authors reported the preparation of azido-decorated 
polymersomes and their conjugation to bioactive ligands, such as a dansyl probe, biotin, and the 
enhanced green fluorescent protein (EGFP). With this aim, an amphiphilic PS-b-PAA was 
prepared by ATRP, and the terminal bromide end groups were substituted for azides. The 
resulting copolymers were allowed to self-assemble into vesicular aggregates that were 
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incubated with aqueous solutions of alkyne-functionalized ligands under standard CuAAC 
conditions (CuSO4, sodium ascorbate, TBTA or BPDS). Average functionalization of peripheral 
azides in the range 40-50% was estimated by fluorescence measurements. Interestingly, no 
change in the vesicles morphology was observed during the CuAAC functionalization process. 
Fig. 16 
In an interesting contribution, Gillies and coworkers reported a similar method for the 
attachment of dendrons onto polymer vesicles directed to enhance the availability of peripheral 
ligands for multivalent interaction with biological targets (78) (Fig. 17). Vesicles were prepared 
by self-assembly of amphiphilic poly(butadiene)-b-poly(ethylene oxide) (PBD-b-PEO) and 
PBD-b-PEO-N3, mixed in different ratios. The functionalization of these vesicles with a 
polyester dendritic scaffold incorporating an alkyne focal point was studied by CuAAC (CuSO4, 
sodium ascorbate, BPDS). Well dispersed vesicles were observed after CuAAC functionalization 
when containing up to 20% of PBD-b-PEO-N3. Under these conditions, full surface decoration 
resulted. In a more recent report, the same group has demonstrated that vesicles functionalized 
with dendritic mannose (CuSO4, sodium ascorbate, BPDS) show an enhanced affinity (of 1-2 
orders of magnitude) towards lectin Concanavalin A (hemagglutination assay), when compared 
to vesicles containing an equal density of non-dendritic mannose (similar results with dextran-
coated iron oxide NP) (79). This binding enhancement has been attributed to the ability of the 
dendrons to effectively display ligands and overcome the steric inhibition by surrounding 
polymer chains, which represents an interesting example of the relevance of the ligand 
presentation on the binding to biological targets. 
Fig. 17 
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The group of O’Halloran and Nguyen has described a drop-in procedure for the 
preparation of polymer-caged nanobins (PCN) from preformed liposomes and a cholesterol-
terminated PAA (synthesized by nitroxide-mediated controlled radical polymerization), followed 
by shell cross-linking (80). PCN surpass some of the problems associated with classical 
liposomes composed of pH-sensitive, amine-modified lipids, and represent a more robust 
delivery platform with pH-responsiveness under acidic conditions. In a recent report, the same 
group has described the preparation of clickable PCN from DOX-loaded liposomes and a 
cholesterol-terminated PAA by covalent cross-linking with an alkyne-modified diamine (81) 
(Fig. 18). The resulting alkyne-functionalized PCN (ca. 125 nm) were decorated with folic acid 
via CuAAC (CuSO4, sodium ascorbate) to give folate-targeted DOX-loaded PCN with 
demonstrated enhanced potency towards folate receptor (FR) positive tumor cells (KB and 
OvCa432), when compared to the untargeted agent. In addition, the folate-targeted PCN could 
discriminate FR positive tumor cells as a function of the level of cellular FR expression, showing 
different degrees of potentiation. 
Fig. 18 
 
Polymeric Capsules and Microspheres. 
Polymer capsules are hollow spherical systems envisioned as promising materials with 
application for the controlled release of functional molecules, such as drugs or enzymes. They 
are usually prepared by layer-by-layer (LbL) assembly techniques comprising the deposition of 
alternating polymer layers over sacrificial cores that are removed at a later stage (82). Although 
LbL has been traditionally driven by electrostatic and hydrogen-bonding interactions, covalently 
bound films offer the advantage of a higher stability due to the formation of cross-linked 
polymer networks (82). For example, the group of Caruso has relied on a CuAAC-based LbL for 
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the preparation of pH-responsive polymer microcapsules by the assembly of ultrathin PAA films 
onto poly(ethylene imine) (PEI)-coated silica particles (83) (Fig. 19). In their approach, PAA 
copolymers incorporating ca. 10% of either alkyne or azide functionalities were synthesized by 
living radical polymerization. LbL assembly was performed by sequentially exposing PEI-coated 
particles to PAA-N3 and PAA-Alk solutions in the presence of CuSO4 and sodium ascorbate. 
After centrifugation, the sacrificial silica cores were removed with fluoride to afford single-
component capsules with wall thickness of 5 nm. One of the advantages of the present approach 
relates to the presence of remaining azide or alkyne groups on the shell of the capsules amenable 
to further selective functionalization. Following the same methodology, biodegradable capsules 
were prepared from homopoly(aminoacids), PLL or poly-L-glutamic acid (PGA), modified with 
azides and alkynes (CuSO4, sodium ascorbate) (84). These capsules showed a reversible pH-
responsive swelling/shrinking behavior, with potential applications for the pH-triggered 
loading/release of bioactive species. In addition, PLL capsules were further PEGylated with 
NHS-PEG-OMe and NHS-PEG-biotin and their interaction with fluorescently labeled BSA and 
streptavidin investigated by flow cytometry. It was found that the non-specific BSA adsorption 
typical of PLL surfaces was considerably reduced in the PEGylated system, whereas streptavidin 
specifically bound to biotin. The biodegradability, low-fouling properties, and targeting ability of 
these capsules make them promising carries for targeted drug delivery. 
Fig. 19 
 
In a similar way, De Geest and coworkers have prepared biodegradable multilayer films 
and hollow capsules based on dextran (85). CaCO3 microparticles precoated with a layer of 
PAA-Alk were assembled by LbL with consecutive layers of azido- and alkyne-dextran under 
CuAAC conditions (CuSO4, sodium ascorbate). Then, hollow capsules were obtained by 
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dissolving the CaCO3 core with EDTA at pH 5.2. The use of carbonate linkages for the 
incorporation of the azide and alkyne functionalities along the dextran chain ensured the 
biodegradability of the resulting capsules. The same authors have also prepared biodegradable 
microcapsules from azido- and alkyne-dextran by a microemulsion method using an external 
aqueous PEG phase (CuSO4, sodium ascorbate) (86). When a FITC-labeled dextran was 
employed, the degradability of the capsules was studied under physiological conditions. It was 
demonstrated that the release of the entrapped FITC-dextran occurred in a controlled fashion, 
and the rate of release could be modulated by the density of cross-linking. 
Caruso and coworkers have also developed a TEC-based LbL strategy that avoids the use 
of coupling reagents or catalysts (87) (Fig. 20). In this approach, a LbL assembly based on 
hydrogen-bonding is preformed on silica particles by depositing consecutive layers of PMAA 
(carrying thiol or alkene functionalities) and poly(N-vinylpyrrolidone) (PVP), that are 
subsequently cross-linked by irradiation with UV light (256 nm, acetate buffer). The efficiency 
of this TEC/LbL strategy was demonstrated by the lack of disassembly at pH 7 under conditions 
leading to hydrogen-bonding disruption. The authors took advantage of the presence of 
remaining thiol or alkene functional groups on the surface of the capsules for the incorporation 
of PEG chains. A related CuAAC strategy has been more recently employed by the same group 
to prepare low-fouling polymer capsules decorated with antibodies showing specific binding to 
colorectal cancer cells (88). In this case, single component PVP capsules were prepared from the 
consecutive assembly of PVP-Alk and PMAA layers via hydrogen-bonding interactions, and 
further CuAAC (CuSO4, sodium ascorbate) cross-linking of the PVP layers with a bifunctional 
azide linker. After removal of the core template and PMAA layers, the remaining alkyne groups 
on the surface of the PVP capsules were conjugated to an azido-PEGylated antibody via CuAAC 
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(CuSO4, sodium ascorbate) in the presence of a Cu(I)-chelating ligand [tris(4-carboxyl-
benzyltriazolylmethyl)amine]. Taking advantage of the same hydrogen-bonding 
assembly/CuAAC cross-linking sequential approach, Caruso and coworkers have recently 
prepared biodegradable capsules with drug-loaded multilayers as promising carrier systems for 
biomedical applications (89). For the preparation of these capsules, layers of PGA-Alk 
with/without covalently conjugated DOX molecules were assembled via hydrogen-bonding with 
PVP on silica templates, and then covalently stabilized using a diazide linker (CuSO4, sodium 
ascorbate). After removal of PVP and the sacrificial template, DOX-loaded PGA capsules were 
obtained with control over drug dose and position in the multilayer system. These PGA capsules 
could be enzymatically degraded to release the active drug, which was localized in the cells 
nuclei. 
Fig. 20 
Although several methods for the preparation of polymeric capsules have been reported so 
far, all of them have in common the necessity of a pre-organized structure or template. A rare 
example of self-assembly into nanosized capsules not requiring the use of templates has been 
recently reported by Sung, Kim, and coworkers (90) . These authors made use of TEC (UV light, 
MeOH) between dithiols and a cucurbit[6]uril carrying 12 allyloxy groups at the periphery for 
the preparation of polymer nanocapsules with high stability and relatively narrow size 
distribution (Fig. 21). Different dyes (carboxyfluorescein, rhodamine) have been entrapped 
inside these capsules. A unique property of these capsules is that they can form highly stable 
host-guest complexes with polyamines by virtue of the unique recognition properties of the 
accessible molecular cavities exposed on the capsule periphery. 
Fig. 21 
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Several strategies taking advantage of click reactions have been also used for the surface 
functionalization of polymeric microspheres. For example, Chen and coworkers used CuAAC 
for the grafting of proteins onto biodegradable microspheres prepared from a P(LA-co-
carbonate) carrying pendant alkyne groups (55). With this purpose, azido-decorated BSA was 
selected as a model protein. The effectiveness of the CuAAC conjugation (CuSO4, Cu wire) was 
demonstrated by confocal microscopy and X-ray photoelectron spectroscopy. In addition, 
CuAAC and TEC chemistries have been employed for the surface functionalization of 
microspheres with polymers as a strategy for enhancing their stability and modifying their 
properties (91, 92). For instance, the groups of Barner-Kowollik, Barner, and Müller have 
recently reported the surface modification of poly(divinylbenzene) microspheres with PNIPAM 
and PHEMA using either TEC (AIBN, acetonitrile) or CuAAC (CuSO4, sodium ascorbate, 
DMF-H2O) strategies (92). 
 
METAL AND SILICA NANOPARTICLES 
During the last decades, hard-matter nanosystems, e.g., AuNP and other noble metal NP, 
MNP, QD, and SiNP, have been extensively investigated because of their unique physical and 
chemical properties, which strongly depend on their size and shape. Although these nanosystems 
are of great interest for researchers in different disciplines, they have been the focus of special 
attention in the biomedical field where they have found application as drug carriers, labeling 
agents, vectors for gene therapy, hyperthermia treatments, and magnetic resonance imaging 
(MRI) (93),(94). In addition, some of these nanostructures offer the possibility of simultaneously 
imaging and treating tumors (theranostic carriers), which may result advantageous over 
conventional chemotherapies. 
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Gold and Noble-Metal Nanoparticles. 
AuNP and other noble-metal NP have emerged as novel nanostructures with exciting 
applications in therapy and diagnosis (e.g, drug and gene delivery, imaging, phototherapy, and 
radiotherapy enhancement treatments). Their low inherent toxicity, high surface area, and 
tunable stability have revealed noble-metal NP as promising platforms for biomedical 
applications (95),(94). Indeed, metallic NP have demonstrated their capability to deliver small 
drugs and large biomolecules such as peptides, proteins, or nucleic acids. Although 
monodisperse metal NP can be easily prepared with extremely small sizes (<30 nm), they usually 
suffer from a reduced chemical stability in solution and a high tendency to aggregate, which may 
lead to the loss of their unique properties. To overcome this shortcoming, the surface of the 
particles is usually functionalized with various types of ligands (e.g., surfactants, polymers, 
dendrimers, biomolecules), which in the case of AuNP typically involves thiolated species. In 
addition to the enhanced stability, the surface functionalization of the particles has been shown to 
be a key parameter for optimizing their bioavailability and non-immunogenicity. As a result, a 
great amount of work has been devoted to the effective functionalization of metal NP. Among 
different strategies used for this goal, those based on click chemistries have revealed extremely 
efficient. 
The first example on the use of an AAC coupling for the surface decoration of AuNP was 
reported by Williams and coworkers (96). Azido-functionalized AuNP were decorated with 
various low molecular weight compounds bearing carbonyl groups adjacent to a terminal alkyne 
for improved reactivity. Although functionalization proceeded in the absence of catalyst, the use 
of organic solvents (dioxane or 1:1 hexane/dioxane) and the inability to achieve complete 
Lallana Page 38 
Click Chemistry for Drug Delivery Nanosystems 
functionalization of the terminal azides render this protocol of low applicability within the 
biomedical field. Subsequent attempts to improve reactivity by the use of organosoluble Cu 
catalysts led to particle aggregation or decomposition (96). These shortcomings have been 
partially solved by Astruc and coworkers who described experimental conditions for quantitative 
CuAAC functionalization of azide decorated AuNP [stoichiometric amounts of CuSO4 and 
sodium ascorbate, room temperature, THF-H2O (1:1), N2 atmosphere] (97). This optimized 
protocol has proven successful for the incorporation of organic, organometallic, dendritic, and 
short PEG chains on AuNP, but the requirement of large amounts of THF makes it unsuitable for 
the conjugation of proteins or nucleic acids. 
Rowan, Brust, and coworkers used CuAAC to efficiently prepare functional enzyme-AuNP 
conjugates from an acetylene-functionalized Thermomyces lanuginosus lipase and azido-
decorated water-soluble AuNP (CuSO4, ascorbic acid) (98) (Fig. 22). The successful formation 
of the protein-particle conjugate was confirmed by gel electrophoresis, while a fluorometric 
lipase activity assay showed that approximately 7 fully active lipase molecules per particle had 
been coupled. Following a similar approach, the group of Rao has recently reported the site-
specific conjugation of bioluminescent Renilla luciferase proteins to AuNP for sensing protease 
activity (99). In addition, the conjugation of azido-functionalized AuNP to an alkyne-modified 
DNA duplex has been reported by the group of Simon (CuBr, TBTA), leading to a chain-like 
assembly of NP on a DNA template (100). More recently, Pang and coworkers described a new 
method for the preparation of azido-bearing AuNP that were functionalized with Alk-HRP via 
CuAAC (CuSO4, ascorbic acid) rendering AuNP-HRP conjugates with retained catalytic activity 
(101). 
Fig. 22 
Lallana Page 39 
Click Chemistry for Drug Delivery Nanosystems 
CuAAC has also been effectively employed for the surface functionalization of silver 
(AgNP) and platinum (PtNP) nanoparticles. In various recent examples, Li and coworkers have 
reported the preparation of highly selective colorimetric sensors for Cd(II) and Co(II) that are 
based on triazole-ester (102) and triazole-carboxyl (103) modified AgNP prepared by CuAAC 
(CuSO4, sodium ascorbate). Similarly, Carrot and coworkers have taken advantage of CuAAC 
(CuBr, PMDETA, dimethylacetamide) to graft biocompatible coronas of PEG and PCL onto 
azido-functionalized PtNP as hybrid structures with potential applications in biodetection (104). 
Other click reactions that have found application for the surface functionalization of noble-
metal NP include Michael addition and Diels-Alder. For instance, the group of Chechik has 
prepared shell cross-linked AuNP with improved stability via Michael addition of various amino-
dendrimers [poly(amido amine) and diaminobutane] to acrylate-terminated particles (105). Also, 
a reversible surface functionalization of AuNP has been accomplished by the group of Beyer by 
means of a Diels-Alder coupling strategy (106). AuNP were first functionalized with a thiol-
terminated PS-b-PEG prepared by Diels-Alder of the PS and PEG blocks. Subsequent thermal 




In the last decade, MNP based on maghemite (γ-Fe2O3) and magnetite (Fe3O4) have 
consolidated as promising materials in biomedicine due to their applications mainly in drug 
delivery (93), MRI, and hyperthermia therapy (107). For these applications, particles must 
display high magnetic saturation, biocompatibility, and a functionalized surface. Although iron 
oxide NP with low dispersity are easily produced, they present an intrinsic instability, which is 
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normally overcome by installing protecting shells. This coverage not only protects MNP from 
degradation, but also provides anchoring sites for functionalization with active molecules or 
reactive groups. 
The group of Turro has reported CuAAC conditions for the surface functionalization of γ-
Fe2O3 NP with low molecular weight organic species and polymers [e.g., -acetylene-poly(tert-
butyl acrylate)] (108). With this aim, short ligands containing carboxylic or phosphonic acid 
groups were designed as strong anchors to bind the NP surface. The presence of either a terminal 
azide or alkyne group in these ligands provided orthogonal functionality on the surface for 
further chemical modification by CuAAC (CuSO4, sodium ascorbate, DMSO-H2O). 
A more biocompatible CuAAC protocol avoiding the need of organic solvents for the 
effective functionalization of MNP (silica oxide-coated Fe3O4) with biologically relevant ligands 
has been described by Lin and coworkers (109). Under the reported conditions [CuSO4, 
tris(carboxyethyl)phosphine (TCEP), TBTA, pH 8], mannose, biotin, the FLAG peptide, the Tn 
antigen, and various proteins [EGFP and maltose binding protein (MBP)] were incorporated on 
the MNP surface and detected using fluorescently labeled antibodies/proteins. When MNP 
containing azides or alkynes at the surface were reacted with complementary alkyne- or azido-
terminated mannose, the alkynated mannose was found to be more efficiently immobilized. This 
faster kinetic of the alkyne counterpart in solution is consistent with the required Cu(I) 
coordination of the alkyne. A similar preference has been reported when labeling CPMV 
(16),(23) and microarray slides (110). Interestingly, the activity of a MBP covalently 
immobilized on the MNP at its C terminus by site-specific CuAAC resulted higher than that by 
random amide bond formation, in agreement with the C terminus being distant from the MBP 
binding site. 
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Prosperi and coworkers have reported an interesting one-pot biofunctionalization of MNP 
(-Fe2O3) via diazo transfer followed by in situ CuAAC (111). Since a common way to modify 
iron oxide NP involves their treatment with γ-aminopropyl triethoxysilane to give amino-
functionalized MNP, these authors explored the possibility of generating azido functionalities 
from the corresponding amines via Cu(II)-catalyzed diazo transfer (112), and their subsequent 
funtionalization via CuAAC. In this one-pot protocol, the Cu(I) species required for the CuAAC 
are easily generated in situ by addition of sodium ascorbate to the Cu(II) salts necessary for the 
diazo transfer (biphasic CH2Cl2-H2O mixture). By application of this procedure, the 
biofunctionalization of MNP with lactose and HSA has proceeded successfully and with retained 
biological activity. 
In a recent report, Mirkin and coworkers employed CuAAC (CuSO4, sodium ascorbate, 
THPTA, DMSO-H2O) to conjugate alkynated oligonucleotides to superparamagnetic iron oxide 
nanoparticles (SPION) functionalized with azides (113). The resulting densily functionalized 
SPION exhibited good cellular uptake by HeLa cells without the need of transfection agents. 
Another example of SPION bioconjugation was reported by Tsourkas and coworkers (114). The 
authors combined expressed protein ligation (EPL) with CuAAC to produce a highly efficient 
and site-specific conjugation strategy that was employed in the preparation of SPION labeled 
with HER2/neu-targeted affibodies. In their approach, the affibodies expressed in bacteria were 
first conjugated to an alkynated fluorescent peptide via EPL. CuAAC was then used for the 
conjugation to azido-labeled SPION (CuSO4, sodium ascorbate, bathocuproinedisulfonic acid). 
The resulting HER2-SPION proved to be highly potent and receptor-specific both in vitro cell 
studies and murine tumor models. In addition, the authors demonstrated the application of this 
EPL-CuAAC strategy to other nanostructures, such as liposomes and dendrimers. 
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MNP are also useful in magnetic hyperthermia, a promising cancer thermotherapy based 
on the exothermic properties of magnetic materials under the influence of an alternating current 
magnetic field (107). In order to specifically target certain tumors, MNP can be conjugated with 
tumor-specific targeting ligands, thereby minimizing undesired side effects. In a recent report, 
Yogo and coworkers prepared FA-functionalized Fe3O4 NP by CuAAC as a cancer targeting 
system with application in hyperthermia treatment (115). Taking into account the low 
chemoselectivity in the derivatization of FA through the carboxylic acids, and the relevance of 
the -carboxyl group for high-affinity binding to the FR, these authors developed a novel 
alkynation method at the heterocycle moiety by treatment with 2,3-dibromopropionyl chloride 
followed by HBr elimination. The resulting Alk-FA was subsequently reacted with azido-
terminated MNP under standard CuAAC conditions (CuI, DMSO-H2O). In a further step, Yogo 
and coworkers prepared SPION functionalized with FA and CD as novel devices for 
simultaneous drug delivery and hyperthermia treatment (116). With this aim, -CD was used as 
nanocontainer for the anticancer drug tamoxifen and as anchoring point for the covalent CuAAC 
(CuI, 70 ºC) functionalization of the SPION with FA. Controlled release of tamoxifen was 
achieved by applying a high frequency magnetic field at an optimum temperature for 
hyperthermia, demonstrating that induction heat can be useful not only for hyperthermia 
treatment, but also as a driving force for drug release. 
Perez and coworkers have also relied on CuAAC for the incorporation of a FA-N3 derivative 
at the PAA-Alk coating of iron oxide NP (CuI, DMF-H2O) (117) (Fig. 23). In addition, taxol and 
a near-infrared dialkylcarbocyanine dye were encapsulated within hydrophobic pockets at the 
polymeric matrix, resulting in a multifunctional (imaging and therapy) and multimodal (magnetic 
and fluorescent) folate-derivatized NP. This system provided targeted drug delivery to lung 
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carcinoma A549 cells that overexpress the FR, without affecting normal cells not overexpressing 
this receptor. Similarly, Weissleder and coworkers prepared dextran-coated SPION that were 
functionalized with the radionuclide 18F in high yield via CuAAC (CuSO4, sodium ascorbate, 
BPDS, DMSO-H2O) for in vivo PET (position emission tomography) imaging (118),(119). 
Fig. 23 
Bhatia and coworkers have investigated the in vivo targeting of iron oxide NP to tumors 
(120). CuAAC (CuSO4, sodium ascorbate) was selected to specifically conjugate the highly 
functionalized cyclic tumor targeting peptide LyP-1 to azido-functionalized PEGylated magneto-
fluorescent NP. LyP-1 has been reported to bind p32, a mitochondrial protein that is both 
overexpressed and aberrantly localized at the surface of tumor cells, macrophages, and lymphatic 
endothelial cells in certain experimental tumors and in human cancers. The resulting NP were 
able to direct their binding to p32-expressing tumor cells in vitro. More importantly, these NP 
have been shown to be stable for more than 5 h in the blood stream after intravenous 
administration, allowing them to extravasate into tumors, penetrate the tumor interstitium, and 
specifically bind to p32-expressing cells. Altogether, these findings not only support the 
excellent features of CuAAC in bioconjugation (orthogonality, efficiency, aqueous 
compatibility), but confirms the stability of the clicked complexes in vivo in the blood and tumor 
environments. 
Although thiol-ene chemistry has been widely employed in the field of polymeric colloidal 
systems, its use for the modification of MNP is still limited, with only a few recent examples 
being reported. One of the main shortcomings in the application of this chemistry to MNP is the 
difficulty in synthesizing alkene-immobilized particles because C-C double bonds undergo 
polymerization at the high temperature required in this process. This limitation has been recently 
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overcome by Yogo and coworkers by employing allyl groups, which do not undergo 
polymerization (121). The authors reported the modification of allyl-functionalized Fe3O4 NP 
with cysteine via a one-pot approach hydrolysis-condensation of Fe(III) allylacetylacetonate and 
TEC (AIBN, EtOH-H2O, 60 ºC). A different strategy was employed by Warner and coworkers, 
who employed Fe3O4-mercaptopropionic acid NP that were further decorated with allyl 
diphosphonic acid or ester ligands by TEC (benzophenone, UV light, H2O or MeOH) (122). 
 
Quantum Dots 
In a similar fashion to noble-metal NP, the inorganic semiconductor nanocrystals known as 
QD have drawn attention in the fields of diagnosis and imaging due to their unique fluorescence 
properties, such as broad absorption, narrow and symmetric emission spectra, long luminescence 
lifetime, and good photostability (123). These optical properties can be tuned as a function of 
size and surface functionality. In spite of these favorable properties, the development of efficient 
and mild bioconjugation strategies for the surface functionalization of QD with biologically 
relevant molecules remains an important challenge to be addressed. Unfortunately, some of the 
currently most popular click reactions have been shown as having severe limitations in their 
application for this goal. For instance, as thiols are commonly employed as stabilizing ligands in 
the preparation of QD, their use for surface functionalization via TEC or Michael additions is 
severely restricted since ligand exchange at the surface of the QD may occur. On the other hand, 
the application of CuAAC suffers from two main drawbacks: (i) The harsh conditions usually 
employed for the preparation of QD are incompatible with the presence of azide or alkyne 
groups in the stabilizing ligands. Accordingly, ligand exchange strategies have to be employed 
for the incorporation of these functional groups, which usually result in reduced 
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photoluminescence quantum yields (PTQY); (ii) Cu catalysts promote a strong inhibition of the 
QD luminescence. These shortcomings were early illustrated by the group of Binder in the 
functionalization of CdSe QD by CuAAC (124). A ligand exchange method was employed to 
decorate trioctylphosphine oxide QD with azide or alkyne functional groups. This process 
resulted in a reduction of PTQY of up to 63%. In addition, CuAAC derivatization of the resulting 
alkyne-functionalized conjugate (CuBr, DIPEA, TBTA, THF) led to a dramatic decrease of the 
PTQY, so that thermal AAC conditions had to be implemented. 
An effective way to overcome the above mentioned drawbacks in QD functionalization is 
the application of convenient Cu-free cycloadditions. In this regard, Texier and coworkers have 
recently described the application of SPAAC for the functionalization of PEG-decorated 
CdSe/ZnS QD and their application to the in vitro imaging of cell membrane glycoproteins 
(125). A cyclooctyne-functionalized QD was prepared from a commercially available 
CdSe/ZnS/PEG-NH2 QD, and then functionalized with an azido-tagged mannosamine in the 
presence and absence of Cu (Fig. 24). In this way, while the SPAAC decoration had a minor 
effect on the PTQY (7% as compared to the cyclooctyne-functionalized QD), the addition of Cu 
led to a marked decrease of more than 65%. 
Fig. 24 
In another approach, Bewendi and coworkers have relied on the inverse-electron-demand 
Diels-Alder cycloaddition between tetrazine and strained alkenes (norbornene) to functionalize 
CdSe QD with both Alexa 594 and an epidermal growth factor (EGF) (126). A ligand exchange 
protocol was employed for the surface doping of QD with multiple norbornene units which 
resulted in a reduction of 40% in the PTQY. No additional quenching of fluorescence occurred 
during Diels-Alder cycloaddition. Interestingly, the EGF-QD proved to be efficient for the in 
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vitro visualization of A431 human carcinoma cells via an in situ labeling approach or with 
preformed conjugates (Fig. 25). 
Fig. 25 
 
Silica Nanoparticles  
SiNP represent another class of nanomaterials with potential applications in drug delivery, 
biodetection, and diagnosis, that possess an excellent biocompatibility, virtually no toxicity, and 
reactive functional groups on the surface available for functionalization (127). Moreover, a 
variety of functional groups can be attached to the silica surface via silane linkers. Following this 
principle, the group of Brittain has reported a combination of RAFT polymerization and CuAAC 
to graft polymers onto SiNP (128, 129). These authors have used an unprotected alkyne-
terminated RAFT CTA to prepare alkyne-terminated polymers and block copolymers, i.e., PS, 
polyacrylamide, PMA, and PS-b-PMA, which were subsequently grafted onto azido-
functionalized SiNP with a high density of grafting (CuSO4, sodium ascorbate, DMSO-H2O or 
DMF-H2O). Using the same CTA, these authors have also reported a tandem RAFT 
polymerization/CuAAC procedure to modify the surface of SiNP in a controlled manner. 
Janus-type SiNP decorated with biomolecules on one hemisphere and biocompatible 
polymer brushes on the other have huge potential applications in targeted drug delivery, as well 
as in the development of switchable devices, optical probes and emulsion stabilizers. Liu, Zhao, 
and coworkers have reported on the use of CuAAC for the sequential functionalization of azide-
modified SiNP embedded on the surface of PS particles used as scaffolds (130) (Fig. 26). In this 
approach, the originally exposed hemisphere of the SiNP was coupled to an alkynated biotin 
derivative by means of CuAAC (CuSO4, sodium ascorbate, t-BuOH-H2O). After removal of the 
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excess of biotin and catalyst by extensive dialysis, the product was collected by centrifugation. 
Then, the PS was removed by dispersion in THF followed by centrifugation, yielding SiNP with 
biotin groups on one hemisphere and azide groups on the other. The bioactivity of the conjugated 
biotin molecules was confirmed by an avidin/HABA competitive binding assay. The remaining 
azide groups on the surface were coupled to an alkynated PEG through a second CuAAC 
(CuSO4, sodium ascorbate, H2O), leading to Janus-type SiNP differently functionalized with 
biotin and PEG at both hemispheres. 
Fig. 26 
Müller and coworkers have reported a new type of hybrid NP consisting of a fluorescent 
inorganic silica-like core and a biocompatible polymer shell containing terminal alkynes 
amenable to functionalization by CuAAC (131). With this aim, block copolymers composed of a 
poly[oligo(ethylene glycol)acrylate] hydrophilic block and a hydrophobic block containing 
trimethoxysilane-functionalized and dye-substituted monomers [(3-acryloxypropyl)-
trimethoxysilane and 1-pyrenebutyl acrylate] were prepared by RAFT polymerization. For the 
polymerization, an alkynated CTA was used to introduce a terminal alkyne group at the 
hydrophilic block. The selection of the trimethoxysilane monomer at the hydrophobic block was 
based on its ability to undergo cross-linking into a stable silsesquioxane network under basic 
conditions for increased stability. Additionally, pyrene containing monomers were included as 
fluorescent tags. After self-assembly of the block copolymers, the resulting micelles were core 
cross-linked by mild treatment with ammonia. The resulting alkynated particles were 
functionalized with Rhodamine B by means of CuAAC under drastic conditions (CuBr, bipy, 80 
ºC, degassed DMF). The potential of these stabilized fluorescent SiNP as biocompatible carriers 
for intracellular delivery was nicely demonstrated by in vitro experiments on lung cancer cells. 
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An interesting report on the dual, bioorthogonal labeling of SiNP has been recently 
described by Kele, Wolfbeis, and coworkers by sequentially exploiting SPAAC and CuAAC 
reactions (132, 133) (Fig. 27). With this aim, SiNP were doped with several copies of a coumarin 
dye and azide reporter groups. The resulting fluorescent NP were then conjugated via SPAAC 
with a synthetic dipeptide containing both a cyclooctyne and a terminal alkyne. Subsequent 
CuAAC labeling of the alkynated peptides with a specifically designed azido-coumarin 
fluorescent dye yielded dually labeled NP as efficient FRET systems. The same authors have 
adapted this strategy for the preparation of diagnostic NP carrying a heptapeptide for detection of 
MMP-2, an enzyme of the collagenase family that plays a key role in several physiological 
processes, including cancer progression. The successful application of the same FRET pair for 
the labeling of proteins (BSA) paves the way for the use of this methodology in the construction 
of dually labeled conjugates for alternative biomedical purposes. 
Fig. 27 
In a recent example, the group of Bein has reported the CuAAC funtionalization of core-
shell colloidal mesoporous SiNP for the preparation of stimuli-responsive porous materials for 
the controlled release of guest molecules (134). Colloidal mesoposous SiNP with azide groups at 
the outer shell were prepared and functionalized by CuAAC (CuSO4, sodium ascorbate, THPTA) 
with double stranded oligodeoxyribonucleotides incorporating an azide and a biotin label at 
different strands. As proof of concept, fluorescein selected as model compound was 
encapsulated, and then the pores closed by complexation to avidin. These functionalized SiNP 
showed a programmable thermoresponsive behavior that allowed the controlled release of the 
guest molecules after melting the DNA molecular valves, a characteristic that is encoded by the 
length of the oligonucleotide employed. 
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CARBON NANOTUBES AND FULLERENES 
CNT	 and	 fullerenes	 are	 nanostructures	 composed	 solely	 of	 carbon	 atoms	 that	 have	
been	 thoroughly	 studied	 in a wide variety of disciplines due	 to	 their	 unique	 physical	 and	
chemical	 properties	 (135). Fullerenes are	 highly	 symmetric	 cage	molecules,	 of	 which	 C60	
(Buckminsterfullerene)	is	the	foremost	member:	a	truncated	icosahedron	with	a	diameter	
of	0.7	nm,	containing	60	carbon	atoms	forming	20	hexagons	and	12	pentagons.	Similarly,	
CNT	are	 composed	of	 carbon	atoms	arranged	 in	benzene	 rings,	 forming	graphene	sheets	
rolled	up	to	give	cylinders	with	typical	diameters	in	the	range	1‐100	nm. Two	main	types	of	
CNT	exist,	single‐walled	(SWCNT)	and	multi‐walled	carbon	nanotubes	(MWCNT),	the	latter	
being	 formed	 by	 several	 concentric	 layers	 of	 rolled	 graphene.	 One	 of	 the	 main	
shortcomings	for	the	development	of	biomedical	applications	of	fullerenes	and	CNT	is their 
poor solubility in aqueous media. As a result, great efforts have been dedicated to increase their 
solubility in water and biocompatibility by different strategies, including the chemical 
modification by click chemistry (136),(137). 
For instance, Adronov and coworkers have reported conditions for the surface 
functionalization of SWCNT by means of CuAAC (138). With this aim, p-aminophenyl 
propargyl ether was reacted with SWCNT using a solvent-free diazotization/coupling procedure 
leading to alkyne-decorated SWCNT with a high degree of functionalization. Conditions for the 
conjugation of this SWCNT with an azido-terminated PS (prepared by ATRP and subsequent 
bromine end-group substitution with NaN3) involved CuI and DBU in DMF. In an attempt to 
improve the biocompatibility and water solubility of SWCNT, Zheng and coworkers have 
exploited this strategy for the covalent linkage of azido-functionalized β-CD (CuI, DBU, DMF, 
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70 ºC) (139) (Fig. 28). The inclusion complexation behavior of this artificial receptor with 
quinine was studied in aqueous solution by fluorescence spectroscopy. The higher 
biocompatibility and rich guest recognition properties derived from the CD make this CD-
SWCNT hybrid a promising platform for materials science and drug delivery applications. 
Fig. 28 
An alternative versatile approach to modify the surfaces of CNT has been described by the 
group of Gao by a combination of CuAAC “grafting onto” and ATRP “grafting from” strategies 
(140). A clickable macroinitiator PBrN3PrMA, carrying bromides for ATRP as well as azido 
groups for CuAAC, was synthesized and coupled to alkynated SWCNT/MWCNT by CuAAC 
(CuBr, PMDETA, DMF). Poly(n-butylmethacrylate), PS, and PEG were subsequently grafted 
onto/from the resulting CNT via ATRP/CuAAC to afford CNT-supported amphiphilic polymer 
brushes with controlled degree of grafting. 
Because of their unique electronic properties, the applications of functionalized CNT are 
mainly focused on the fields of solar energy conversion, electronics, and sensing. In this regard, 
several groups have reported the application of CuAAC for the functionalization of CNT with 
AuNP (141), MNP (142), and porphyrin dendrons (143), as potential platforms for novel 
electronic materials. In addition, CuAAC has been applied for the preparation of sugar-based 
amphiphiles capable of binding CNT surfaces through - interaction and function as 
homogeneous bioactive coatings to reduce cytotoxicity and facilitate targeting (144). The 
combination of these principles (good electronic properties, reduced toxicity and active 
targeting) points out potential applications of CNT in drug delivery, where click chemistry will 
play a critical role as coupling technology. 
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Functionalized fullerenes, especially those based on the C60 platform, have been recently 
investigated as novel materials in nanomedicine. Thus, C60 has been used for the development of 
HIV-1 protease inhibitors, drug and gene delivery systems, or novel photodynamic therapy and 
MRI contrast agents (137). 
The application of CuAAC for the construction of functionalized fullerenes has allowed 
the preparation of complex conjugates where previous synthetic approaches failed. In one 
example by Isobe, Nakamura, and coworkers, C5-symmetric multivalent glycoconjugates with 
suitable spatial orientation for the inhibition of pentameric Shiga-like toxin proteins have been 
prepared from a pentaalkynyl C60 derivative and various unprotected azido-functionalized 
carbohydrates, including the Pk trisaccharide present in the natural ligand globotriaosylceramide 
(Gb-3) (CuBrꞏSMe2, i-Pr2EtN, DMSO, 40 ºC) (145) (Fig. 29). 
Fig. 29 
Shortly after, Nierengarten and coworkers prepared symmetrical C60 hexakis-dendritic 
adducts bearing 12 peripheral azide or alkyne groups, that were functionalized with various 
ligands, including ferrocene, a porphyrin, and G2 Fréchet-type dendrons (CuSO4, sodium 
ascorbate, biphasic CH2Cl2-H2O mixture) (146),(147) (Fig. 29). This methodology also enabled 
the preparation of difunctionalized fullerenes via a sequential double CuAAC approach starting 
from a C60 hexaadduct bearing 10 azides and 2 TMS-protected alkyne groups (147). Biologically 
relevant ligands such as carbohydrates have been attached to the periphery of C60 using this 
methodology. Some of the resulting “sugar balls” have been shown to be efficient inhibitors of 
glycosidase activity, and in some cases, a positive multivalent effect was observed (148). 
CuAAC has also allowed the preparation of polymer-C60 hybrids. In the first example, 
reported by the group of Cheng (149), a PS-C60 conjugate was obtained by reacting azido-
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terminated PS of different molecular weights with a monoalkynated fullerene derivative (CuBr, 
PMDETA, toluene). 
Steinmetz, Finn, Manchester, and coworkers have explored the advantages of combining 
fullerenes and viral nanoparticles (VNP) for biomedical applications, such as photodynamic 
tumor therapy (150). VNP were decorated with C60 using classical amide formation conditions 
and CuAAC. An Alk-PEG-C60 conjugate was prepared and reacted with an azide modified VNP 
(CuSO4, sodium ascorbate, THPTA, aminoguanidine), resulting in soluble and stable hybrids 
with a significantly higher loading than via amides. The covalent incorporation of C60 was 
verified by Western blotting and STEM. The structural integrity of the VNP-PEG-C60 hybrid was 
confirmed by SEC, TEM, STEM, and native gel electrophoresis. The cellular uptake of a dye-
labeled VNP-PEG-C60 was studied in HeLa human cancer cells using confocal microscopy, 
which revealed that internalization was not inhibited by the C60 units. 
The application of TEC to the functionalization of fullerenes has been limited by their 
reactivity towards thiyl radicals (151), which can lead to undesired byproducts. In spite of this, 
the group of Nierengarten has taken advantage of the higher reactivity of the methacrylate group 
to decorate the surface of C60 with model thiols (AIBN, benzene, 80 ºC) (152). In addition, the 
authors exploited the orthogonality of TEC (AIBN, degassed THF, reflux) and CuAAC (CuSO4, 
sodium ascorbate, biphasic CH2Cl2-H2O mixture) to demonstrate the advantages of sequential 
click reactions to yield differently functionalized fullerenes with potential applications in the 
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BNP are supramolecular protein assemblies such as viruses, virus-like particles, ferritins, 
and enzyme complexes, receiving great attention as pre-fabricated, biocompatible, and 
biodegradable scaffolds for a wide variety of nanotechnology applications, including drug 
delivery (153). Since azides and alkynes are inert towards biological environment, CuAAC has 
revealed as an excellent tool for the functionalization of BNP. Fokin, Sharpless, Finn, and 
coworkers reported the first CuAAC functionalization of a BNP, the CPMV, a 31 nm structurally 
rigid icosahedral assembly of 60 identical copies of a two-protein asymmetric unit around a 
single-stranded RNA (16). With this purpose, the surface of CPMV was first decorated with 60 
azide or alkyne groups at reactive lysine or cysteine residues in a controlled way. Adequate 
CuAAC experimental conditions involved the use of CuSO4, TBTA, and either TCEP or a Cu 
wire (5% t-BuOH in PBS, pH 8). Under these conditions, quantitative functionalization of 
CPMV with 60 copies of a complementary azide- or alkyne-functionalized fluorescein resulted, 
without compromising the structural integrity of the viral particles. 
In spite of the successful bioconjugation achieved, some limitations of CuAAC for the 
functionalization of biomacromolecules were pointed out by the authors in this study. Thus, in 
the absence of TBTA, viral capsides resulted either degraded or aggregated by Cu ions or the 
reducing agents used to generate Cu(I) in situ (16). As a result, great efforts have been devoted to 
minimize these shortcomings of CuAAC in bioconjugation. As previously described in this 
Expert Review, this goal has been generally achieved by the proper selection of a Cu(I)-chelating 
ligand, intended to stabilize the oxidation state of Cu(I), increase the reaction rate, and sequester 
Cu ions to facilitate purification. TBTA is indeed a good example of Cu(I)-chelating ligand. Its 
tetradentate binding ability allows the formation of Cu(I) chelates so stable, that exclusion of O2 
from the reaction medium is not required in order to avoid the oxidation of Cu(I) (20). On the 
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other side, its poor solubility in water has encouraged the search of alternative ligands with 
increased solubility (i.e., BPDS and THPTA). 
BPDS in the presence of Cu(I) salts [e.g., Cu(MeCN)4OTf, Cu(MeCN)4PF6, CuBr] 
represents an interesting water soluble alternative to TBTA. Finn and coworkers have reported 
the successful CuAAC functionalization of CPMV under these conditions with a plethora of 
biologically relevant substrates, such as complex carbohydrates (sialyl Lewis X, blood group A 
antigen, tri-LacNAc, globo-H, and a tetrasaccharide galectin-4 ligand), peptides (RGD and a 
portion of the protective antigen of anthrax toxin), polymers (PEG and a glycopolymer produced 
by ATRP), a DOTA-Gd complex, and the iron carrier protein transferrin [HEPES (usually better 
results than Tris or PBS buffers), pH 8, rigorous exclusion of O2] (23),(154, 155, 156) (Fig. 31). 
Interestingly, the high catalytic activity of BPDS renders unnecessary the use of a large excess of 
coupling probes. As previously observed with MNP (109) and microarray slides (110), CuAAC 
on CPMV containing peripheral azides proceeded more efficiently than with alkynes. 
Fig. 31 
The BPDS/Cu(I) system has been also exploited by Finn, Manchester, and coworkers for 
the functionalization of CPMV with FA (157). With the aim of overcoming the natural targeting 
ability of CPMV towards several mammalian cell lines and tissues in vivo, and redirecting it to 
alternative targets, FA was selected as a model ligand. FA was attached to CPMV by CuAAC 
through a short PEG linker, and the specific recognition by tumor cells bearing the FR studied. 
The incorporation of PEG-FA completely eliminated the background binding of CPMV, and 
allowed the specific recognition by tumor cells bearing the FR. The analysis different loadings of 
FA on CPMV revealed that high density loadings may not be necessary for efficient targeting to 
tumor cells. In a more recent contribution, the group of Finn has also relied on the BPDS/Cu(I) 
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system for the CuAAC functionalization of the capsid of bacteriophage Q labeled with 
unnatural amino acids, containing azides or terminal alkynes introduced by site-directed 
mutagenesis (158). 
The combination of BPDS and Cu(I) salts has been adopted by many other research groups 
as standard CuAAC conditions for the bioconjugation of BNP. For example, the group of Fisher 
and Manchester used these conditions for the functionalization of the rod-shaped potato virus X 
with fluorescent dyes (159). In another example, Wang and coworkers chemoselectively 
functionalized the surface of horse spleen apoferritin, a cage-like protein structure composed of 
24 structurally equivalent subunits (160). A total of 4 reactive lysines per subunit (K83, K97, 
K104, and K143) were first functionalized with terminal alkynes and subsequently decorated 
with an azido-coumarin by CuAAC. Interestingly, while initial CuAAC attempts with 
CuSO4/ascorbic acid or CuSO4/TCEP led to aggregation or denaturation of the apoferritin, the 
use of CuBr/BPDS afforded functionalized intact protein particles as confirmed by size-
exclusion FPLC and TEM. The incorporation of one coumarin per subunit was confirmed by 
MALDI-MS analyses of a V8 protease digests. 
More recently, Carrico and coworkers have employed these CuAAC conditions 
(CuBr/BPDS) for the selective functionalization of human adenovirus type 5 (161). Effective 
decoration of the viral surface was accomplished via metabolic incorporation of N-
azidoacetylglucosamine into the fiber protein during virus production, and subsequent CuAAC 
conjugation with alkynated derivatives of the FLAG peptide, tetramethylrhodamine, and FA. 
Remarkably, a folate-decorated adenovirus encoding a GFP in the viral genome showed a 3-4-
fold increase GFP expression in FR-expressing mouse breast carcinoma cells (4T1) compared to 
the unmodified adenovirus. 
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Young, Douglas, and coworkers also reported a CuAAC strategy based on the use of 
BPDS and Cu(MeCN)4OTf for the synthesis of a cross-linked dendritic network in the interior of 
the porous heat shock protein cage (Hsp) (162). With this aim, a mutant HspG41C carrying a 
genetically introduced cysteine reactive site on the interior surface of each 24 identical subunits 
was selected. Dendritic structures were grown within the cage by reacting the cysteine residue 
with N-propargyl bromoacetamide and subsequent iterative CuAAC couplings with 2-azido-1-
azidomethyl ethylamine and tripropargyl amine to generate an internal branched structure that 
finally cross-linked (Fig. 32). The resulting internally functionalized cages were monodisperse 
and very similar in size to the native protein cage (SEC, TEM, DLS). In addition, the cross-
linked cages benefited from extended thermal stability to at least 120 °C and an enhanced 
internal carrying capacity with potential application in drug delivery. 
Fig. 32 
As seen above, the use of BPDS in connection with Cu(I) salts has allowed the efficient 
and clean functionalization of various types of BNP under conditions that avoid degradation and 
aggregation by Cu, ROS, and reducing agents. Nevertheless, the high sensitivity of this catalytic 
system to air oxidation (requiring rigorous exclusion of O2 or the use of a sacrificial reducing 
agent) demanded more user-friendly reaction conditions for the widespread application of 
CuAAC in bioconjugation. With this aim, the group of Finn has developed new experimental 
procedures, including an electrochemically triggered CuAAC (25) and the use of the water 
soluble ligand THPTA (22). In the first approach, Cu(II) is electrochemically reduced to Cu(I) in 
the presence of the coupling substrates and BPDS (Fig. 4). Under these conditions, no reducing 
agent is required and the O2 present in the reaction medium is reduced to H2O (i.e., O2 + 4H+ + 
4e- → 2H2O). Consequently, degradation processes by ROS or reducing agents are minimized 
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(25). The versatility of this methodology was demonstrated by conjugating up to 650 copies of 
an alkynated selenomethionine to azido-modified bacteriophage Q (CuSO4, BPDS, electrolysis, 
-200 mV) with comparable outcome to that previously reported under O2-free conditions (25) 
(Fig. 4). The second approach involves a protocol relying on the simplicity and reliability of the 
Cu(II)/ascorbate system and the water solubility of THPTA (22). THPTA, originally reported by 
the group of Fokin (20), had been previously claimed by Brown and coworkers as an effective 
ligand for the harmless CuAAC functionalization of nucleic acids (26). In addition to the known 
Cu(I)-chelating properties, Finn and coworkers have reported THPTA as radical scavenger, 
strongly accelerating the decomposition of H2O2 generated in the reaction medium [5-fold excess 
of THPTA vs Cu(I)]. Under these conditions, the use of the carbonyl capturing reagent 
aminoguanidine (stoichiometric aminoguanidine/ascorbate ratio) is also recommended to 
minimize the adverse effects of ascorbate byproducts on amine-containing substrates. Following 
this protocol, functionalization of bacteriophage Q with up to 630 copies of a fluorescein dye or 
50 BSA molecules has been efficiently accomplished (Fig. 4). 
The advantages of this CuAAC bioconjugation protocol [Cu(II)/ascorbate/THPTA] have 
been also demonstrated by the group of Douglas for the internal functionalization of the mutant 
protein cage HspG41C with a branched iron-phenanthroline-based coordination polymer (163). 
Also, by the group of Finn for the covalent functionalization of bacteriophage Q with C60 
Buckyballs (150), and the human iron-transfer protein transferrin, a high affinity ligand for 
receptors upregulated in a variety of cancer cells (164). The transferrin conjugation to Q 
particles allowed specific recognition by transferrin receptors and cellular internalization through 
clathrin-mediated endocytosis, as determined by fluorescence microscopy on cells expressing 
GFP-labeled clathrin light chains. More recently, these conditions have been also applied by 
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Finn and coworkers for the labeling of mammalian cells in culture with no loss in cell viability (5 
min incubations) (165), paving the way for the safer application of CuAAC in bioorthogonal 
chemical reporter strategies. 
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CONCLUSIONS 
Over the past few decades, various generations of nanosized drug delivery systems (DDS) 
have been developed for the controlled administration of drugs into the body. Organic synthesis 
has accompanied this process by providing synthetic tools for the preparation of novel materials 
for the construction of DDS with new properties, as well as for the efficient bioconjugation of 
drugs, polymers, and targeting ligands. Indeed, as this ability of putting together small building 
blocks into larger structures has been at the core of evolution, Nature has inspired chemists in the 
search for more efficient processes with production of minimal waste. In this context, and in an 
effort to focus the attention on the easy production of properties rather than on challenging 
structures, Sharpless and coworkers introduced in 2001 the concept of click chemistry. The idea 
was to confine the whole range of chemical transformations to a set of orthogonal processes with 
high thermodynamic driving force, allowing the efficient and easy transformation of "spring-
loaded" starting materials into new substances with useful properties. Four main groups of click 
reactions were defined on this basis: additions to carbon-carbon multiple bonds, nucleophilic 
substitutions, cycloadditions, and carbonyl chemistry of the "non-aldol" type. Among them, the 
Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) has emerged as a paradigm in click 
chemistry, attracting most attention, and finding application in many areas of research. In 
addition, as the click concept clearly goes beyond CuAAC, it has also triggered the search for 
more efficient, orthogonal, and harmless conjugation protocols of wide application, and 
experimental simplicity for non-specialists. Also, the introduction of the click concept has 
attracted a renewed interest on the use of efficient classical transformations. Firmly established 
reactions before the click era, such as the thiol-ene coupling, Michael addition, or Diels-Alder, 
are clear examples of this type. 
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As shown in this Expert Review, drug delivery has greatly benefited from click chemistry. 
Numerous examples of click procedures have been recently reported for the preparation and 
functionalization of nanosized DDS, including polymeric micelles and nanoparticles, liposomes 
and polymersomes, capsules, metal and silica nanoparticles, carbon nanotubes and fullerenes, or 
bionanoparticles. In addition, great efforts have been focused on the development of efficient 
bioconjugation protocols to ensure fast and high yielding functionalizations. 
Nevertheless, the rapid and favorable acceptance of the click concept in drug delivery and 
other areas should not screen challenges still ahead. For instance, a survey of the literature 
reveals that in many publications entitled as "click", some of the fundamental concepts of click 
chemistry are being misinterpreted. Also, taken CuAAC as a leading example of a recently 
described click reaction, it is interesting to note that under the original conditions reported by 
Fokin, Sharpless and cowokers, the presence of Cu and reducing agents revealed detrimental for 
biomacromolecules (i.e., nucleic acids, proteins, polysaccharides), and hence reaction conditions 
have been adapted to ensure their harmless functionalization. 
As a result, the complexity of nanosized DDS (where polymers, low molecular weight 
molecules, and biomacromolecules coexist into well-organized nanostructures) reveals as an 
attractive test ground with rich future for the application/development of established/new click 
reactions. In addition, the development of new processes with high reaction kinetics and 
biocompatibility within the cellular environment, the selective labeling of specific targets using 
wild metabolic routes, or the design of easily accessible reactive tags with long shelf-life are 
undoubtedly roads to ride for the biomedical applications of click chemistry, where drug delivery 
will find an endless source of inspiration. 
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Figure Legends 
 
Figure 1 Synthetic sequence reported by Sharpless and coworkers to highlight the four groups of 
click reactions originally proposed (ref (8)). 
 
Figure 2 Thermal a) and Cu(I)-catalyzed b) versions of the Huisgen 1,3-dipolar AAC. 
 
Figure 3 Cu(I)-chelating ligands commonly employed in CuAAC bioconjugation. 
 
Figure 4 Functionalization of bacteriophage Q via different CuAAC bioconjugation protocols: 
Cu(I), BPDS, O2-free; Cu(II), BPDS, electrolysis; Cu(II), ascorbate, THPTA, aminoguanidine 
(ref (25) and (22)). 
 
Figure 5 SPAAC a), and various activated cyclooctyne derivatives used in bioconjugation b). 
 
Figure 6 RAFT/TEC synthetic strategy for the preparation of glucose functionalized copolymers 
and thermoresponsive micelles. [LCST = lower critical solution temperature]. Reprinted with 
permission from ref (39). 
 
Figure 7 Synthesis of dendron-like PCL-b-PEG-b-dendron-like PCL triblock copolymers by 
CuAAC and self-assembly into flower-like micelles. Reprinted with permission from ref (40). 
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Figure 8 Formation and cellular behavior of core-shell micelles with switchable tumor-triggered 
targeting properties. [NAS (N-acroyloxysuccinimide); MPEG (methoxy-PEG); Ad (adamantyl); 
NCCM (non-covalently connected micelle)]. Reprinted with permission from ref (44). 
 
Figure 9 General approaches to the preparation of functionalized PACA micelles. Reprinted 
with permission from ref (47). 
 
Figure 10 Self-assembly of P(TMCC-co-LA)-g-PEG-furan and preparation of immuno-micelles 
via Diels-Alder functionalization with maleimide-modified antibodies. Reprinted with 
permission from ref (49). 
 
Figure 11 Preparation of heterodifunctionalized core-shell micelles via sequential 
aminolysis/Michael addition and CuAAC functionalizations. Reprinted with permission from ref 
(51). 
 
Figure 12 Conjugation of hemoglobin to the core surface of PLA-b-PMPC-b-PEG micelles via 
CuAAC. [CO-Hb (carbonylhemoglobin)]. Reprinted with permission from ref (57). 
 
Figure 13 CuAAC functionalization of PEG-dendritic block copolymers and formation of PIC 
micelles with PLL. Reprinted with permission from ref (61). 
 
Figure 14 CuAAC stabilization of alkyne-modified micelles with azido-dendrimer for the 
preparation of shell cross-linked NP. Reprinted with permission from ref (65). 
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Figure 15 Preparation of immuno-NP via SPAAC decoration. [PEGO (poly(ethylene 
glycol)octyne); EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide)]. 
 
Figure 16 Preparation of PS-b-PAA polymersomes with peripheral azide groups and their 
functionalization with Alk-EGFP. [TBAF (tetra-n-butylammonium fluoride)]. Reprinted with 
permission from ref (77). 
 
Figure 17 General approach for the surface functionalization of vesicles with dendritic wedges. 
Reprinted with permission from ref (78). 
 
Figure 18 CuAAC strategy for the preparation of DOX-loaded, folate-conjugated PCN [DXR = 
doxorrubicin (DOX)]. Reprinted with permission from ref (81). 
 
Figure 19 Schematic representation of the LbL/CuAAC preparation of triazole cross-linked pH-
responsive polymer microcapsules from a silica template. Reprinted with permission from ref 
(83). 
 
Figure 20 Preparation of (PVP/PMA-thiol/PVP/PMA-Alk)-coated microparticles by LbL 
assembly, followed by PEGylation, cross-linking stabilization via TEC, and removal of the PVP 
layers and silica template. Reprinted with permission from ref (87). 
 
Figure 21 Synthesis of (allyloxy)12cucurbit[6]uril polymer nanocapsules via TEC cross-linking. 
Reprinted with permission from ref (90). 
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Figure 22 Functionalization of AuNP with a lipase via CuAAC. Reprinted with permission from 
ref (98). 
 
Figure 23 Schematic representation of the preparation of theranostic and multimodal iron oxide 
NP. [NIR (near-infrared); paclitaxel = taxol. DiI (dialkylcarbocyanine fluorophores)]. Reprinted 
with permission from ref (117). 
 
Figure 24 SPAAC surface functionalization of QD in the presence and absence of Cu(I), and 
effect of reaction conditions on QD luminescence. Reprinted with permission from ref (125). 
 
Figure 25 Labeling of cells with preformed QD-EGF constructs a). In situ conjugation of QD to 
EGF on live cells via tetrazine-norbornene Diels-Alder cycloaddition b). Reprinted with 
permission from ref (126). 
 
Figure 26 Schematic representation of the preparation of Janus-type SiNP. Reprinted with 
permission from ref (130). 
 
Figure 27 Schematic representation of the SPAAC conjugation of a cyclooctyne/alkyne peptide 
to azido-functionalized fluorescent SiNP, and their further CuAAC labeling with an azido-FRET 
acceptor. [PEP (peptide)]. Reprinted with permission from ref (133). 
 
Figure 28 Synthesis of CD-modified SWCNT. Reprinted with permission from ref (139). 
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Figure 29 CuAAC functionalized fullerenes prepared by the groups of Isobe and Nakamura 
(left), and Nierengarten (right). Reprinted with permission from ref (145) and (147). 
 
Figure 30 Functionalization of fullerene hexaadducts by means of sequential CuAAC and TEC. 
Reprinted with permission from ref (152). 
 
Figure 31 Functionalization of CPMV with biologically relevant ligands, polymers, and imaging 
agents via CuAAC. 
 
Figure 32 Rationale and strategy for fabricating a hybrid protein cage/dendritic structure. 
Reprinted with permission from ref (162). 
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